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The nascent nucleocapsids of Herpes Simplex Virus (HSV) egress from the in-
fected cell nuclei by budding at the inner nuclear membrane (INM), and become en-
veloped primary virions in the perinuclear space. The envelope then fuses with the 
outer nuclear membrane (ONM) and the capsids are released into the cytosol, where 
they acquire tegument proteins and the final envelope at the trans-Golgi network and 
are delivered to the extracelluar space via secretory vesicles. This complicated process 
involves interactions between both viral and host factors. 
The products of viral UL31 and UL34 genes form a complex on the INM that is 
essential to initiate the primary envelopment reaction. The proper positioning of this 
complex requires a kinase encoded by the viral US3 gene. In the absence of pUS3 
kinase activity, pUL31/pUL34 complexes aggregate on the nuclear rim and perinuclear 
virions accumulate within invaginations of the INM. I discovered that the nuclear lam-
ina was dramatically perforated near those pUL31/pUL34 aggregations, and identified 
lamin A/C as a putative substrate of US3 kinase in vitro. The kinase activity was found 
to be sufficient to induce partial dissolution of lamin A/C from permeabilized cell nu-
clei. Two-dimensional electrophoretic analyses confirmed that lamin A/C was phos-
phorylated in HSV-infected cells, and the optimal phosphorylation required US3 
kinase activity. These data suggest that US3 kinase activity regulates HSV-1 capsid 
nuclear egress at least in part by phosphorylation of lamin A/C. 
Lamins A/C and B1 were shown to interact with pUL34. To determine the roles 
of these interactions on viral infectivity and pUL34 targeting, the localization of pUL34 
was examined in lamin knockout mouse embryonic fibroblasts (MEFs) in the presence 
or absence of pUS3 kinase activity. It was determined that both lamin proteins directly 
or indirectly modified pUL34 distribution but neither was required for its INM target-
ing during viral infection. The elimination of lamin B1 made cells less permissive for 
viral replication, whereas lamin A/C was dispensable for viral infection. Furthermore, 
in cells infected by the US3 defective virus, the lack of lamin A/C precluded accumu-
lation of perinuclear virions and partially restored replication of this virus. These ob-
servations reveal different roles of specific lamins in HSV infection, suggesting that 
lamin A/C normally impedes viral nuclear egress and that US3 kinase helps alleviate 
this impediment, whereas lamin B1 is necessary for efficient viral replication, proba-
bly through its effects on many cellular signaling pathways. 
pUL31, the binding partner of pUL34, is also a substrate of pUS3. The N-terminus 
of pUL31 was found to be critical for the protein’s normal function and contains mul-
tiple phosphorylation sites for US3 kinase. The phosphorylation was not essential for 
productive infection, but was necessary for optimal viral growth kinetics. Phosphory-
lation-deficient pUL31 caused pUL31/pUL34 complex aggregation as well as perinu-
clear virion accumulation, similar to the phenotype caused by abolishing US3 kinase 
activity. Mimicking phosphorylation of pUL31 by replacement of phosphorylated resi-
dues with glutamic acid largely restored the smooth distribution of pUL34/pUL31, and 
precluded the perinuclear virion herniations, regardless of US3 kinase activity. How-
ever, the pseudo-phosphorylated protein hindered the primary envelopment of capsids. 
These results indicate that pUL31 phosphorylation is a dynamic event, which mediates 
pUS3 regulatory functions in both primary envelopment of nucleocapsids and subse-
quent de-envelopment of perinuclear virions. 
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CHAPTER I 
INTRODUCTION 
Herpes simplex viruses are members of the Herpesviridae family. Members of 
this family are enveloped DNA viruses that produce life-long infections (168). Based 
upon details of tissue tropism, pathogenicity, and behavior under conditions of culture 
in the laboratory, the herpesviruses have been classified into three groups (171, 172): 
the alpha-herpesviruses which are neurotropic, have a rapid replication cycle and usu-
ally a broad host and cell range, and the beta- and gamma-herpesviruses which differ 
in genome size and structure. Both beta- and gamma-herpesviruses replicate more 
slowly and in a much more restricted range of cells of glandular and/or lymphatic ori-
gin. The human herpesviruses include herpes simplex virus type 1 and type 2 (HSV-1 
and HSV-2, respectively), varicella-zoster virus (VZV), human cytomegalovirus 
(HCMV) and Epstein-Barr virus (EBV) (168). 
Herpes simplex viruses belong to alpha-herpesviruses (168). The infection by 
HSV-1 and -2 initiates at oral and genital mucosa respectively (226, 227). Viruses en-
ter sensory nerve termini and travel through neuronal axons in a retrograde manner to 
the dorsal root and trigeminal ganglia, where latent infection is established (8, 9, 42, 
65). During latency, viruses maintain their quiescent genomes in the neuronal nucleus 
(41, 122, 167). However, lytic infection can be reactivated by a variety of stimuli in-
cluding mental stress, menstruation, UV light etc (170, 227). Once activated, viruses 
resume replication and can disseminate progeny into nearby cells, peripheral nerve 
endings in skin, and/or the central nervous system (65, 212, 226). The release of vi-
ruses from the nerve terminals permits reinfection of the original epithelial tissues 
(e.g., creation of “cold sore” for HSV-1 or “genital herpes” for HSV-2). These lesions 
can be painful and recur for the host’s entire life. If the infection spreads into the cen-
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 tral nervous system, it may result in life threatening, or fatal viral encephalitis. There 
is no cure for herpes infection currently, as neither vaccines nor antiviral drugs can 
affect the latent virus. 
HSV-1 virion structure 
The herpesvirus virion is composed of four elements (Fig. 1.1A): a core contain-
ing a linear double-stranded DNA genome, an icosahedral capsid protecting genetic 
material, a tegument protein matrix surrounding the capsid, and an outer lipid bilayer 
envelope. The HSV-1 particle is approximately 186nm in diameter (73, 169). Twelve 
different viral glycoproteins and at least 2 nonglycosylated proteins are embedded in 
the envelope (170). The tegument contains around 20 different proteins and is largely 
unstructured. Abundance of individual components varies from 100 to 2000 copies per 
virion (74, 112). The 125nm diameter capsid is not centrally positioned (73). It is 
composed of 150 hexons and 12 penton capsomeres, which are composed of four pro-
teins. VP5, the major capsid protein, is present in five copies in each penton and six 
copies in hexon (179). Six copies of VP26 form a ring on the top of VP5 in each 
hexon (240). The adjacent capsomers are linked together by triplexes formed by one 
copy of VP19C and two copies of VP23 (239). There are also a number of minor cap-
sid-associated proteins such as UL6 protein and VP24; they are not capsid building 
blocks, but are involved in DNA encapsidation (209, 222). 
Genome organization 
The 152 Kbp genome of HSV is packed in a liquid crystalline array in the capsid 
(16). As represented in Fig 1.1B, it contains two covalently linked segments of nonre-
peated DNA designated unique long (UL) (128 Kbp) and unique short (US) (25 Kbp) 
(169). These unique components are flanked by inverted repeats of DNA designated 
RL and RS respectively. A common nomenclature for HSV genes refers to their
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Figure 1.1 Structure of herpes virion and viral genome. (A) Electron micro-
gragh (left) of a herpesvirus particle and schematic representation (right) of 
virion structural components [reprinted from reference (124)]. (B) Schematic 
illustration of HSV genome. The genome is divided into a UL and US region. 
The unique sequences are separated by inverted repeats (shown as boxes and 
designated as RL and RS). 
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 location in the genome, e.g. UL1-56, US1-11. Genes mapped within the inverted re-
peats are present in two copies e.g. ICP4 (RS1). 
The RL sequences can be more specifically indicated as ab at the genome termi-
nus and b’a’ in the opposite orientation at the L/S junction, whereas RS is represented 
as a’c’ and ca. More than one “a” sequence can be present in the terminal RL, while 
the terminal RS invariably contains a single “a” sequence (220). The “a” sequence 
structure is highly conserved but its sequence composition and size vary from strain to 
strain. The “c” sequences harbor two copies of a viral DNA replication origin (oriS). 
A third origin, oriL, was identified in the middle of the UL component. The three ori-
gins function redundantly such that deletion of oriL or both oriS have only slight im-
pacts on viral replication (5, 169). 
Until now, more than 90 unique transcriptional units have been identified on both 
strands of the genome; 84 of them encode proteins (170). Of the proteins potentially 
encoded, it is estimated that more than 40 accompany the viral particle itself, while the 
remainder are thought to modulate infectivity. With few exceptions, most viral genes 
do not contain introns and each produces a single protein (169). So far, more than two 
gene clusters have been noted. For example, a set of beta genes involved in viral DNA 
synthesis is located near the oriL, and a set of gamma genes encoding glycoproteins is 
positioned within the US component (170). 
HSV-1 replication 
HSV infection begins when virus penetrates into a host cell by fusion of its enve-
lope with the cell membrane. The de-enveloped particle is then transported to the nu-
clear pore, through which genomic DNA is released into the nucleus for transcription 
and genome replication. Assembly of new capsids and genome packaging take place 
in the nucleus. Following that, nucleocapsids bud across the nuclear membrane into 
4 
 the cytoplasm, where they acquire tegument and viral envelopes at the Golgi network 
to become a mature virion. Afterwards, the progeny virus can be released into the ex-
tracellular space by exocytic vesicle transport, or can spread to neighboring cells 
through virus-induced cell fusion or direct cell-cell spread. 
Viral entry 
Two pathways coexist for HSV to enter cells, but which serves as a primary route 
is cell-type dependent (65). In cells like Hep2 cells, Vero cells and neurons, viral entry 
is mainly mediated by direct fusion at the plasma membrane and subsequent release of 
the capsid into cytosol. For keratinocytes and HeLa cells, the virus is first endocytosed 
and later fuses with the membrane of endosomal vesicles (141). Whatever pathway is 
used, recognition of and binding to target cells and subsequent fusion are key events, 
which depend upon interactions between cell surface receptors and viral glycoproteins 
on the viral envelope. By current count, there are at least 12 glycoproteins on the viral 
envelope, and four of these glycoproteins: gB (UL27), gD (US6), and the complex of 
gH (UL22) and gL (UL1) are known to be essential for entry in both pathways (161). 
Attachment to the cell surface involves at least three glycoproteins—gB, gC 
(UL44), and gD. gC and gB mediate the initial interaction with cells, recognizing 
heparan sulfate proteoglycans (HSPGs) on the cell surface; gC is not essential for en-
try inasmuch as gB can substitute for gC (75). Simultaneous mutations of the HSPG-
binding sites of gC and gB abolish high-affinity interaction with HSPGs and decrease 
the efficiency of entry (54, 115). This initial heparin-sensitive attachment to cells is 
relatively weak, and is followed by more stable association to enable entry; the latter 
step apparently requires gD. Three cellular receptors can bind gD and mediate HSV 
entry independently: herpesvirus entry mediator (HVEM), nectins, or 3-O-
sulfotransferase-modified heparan sulfate (3-O-HS). These molecules do not act as co-
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 receptors for entry, and the existence of a co-receptor was not known until a recent 
discovery that association of immunoglobulin-like type 2 receptor (PILRα) with gB 
was required for entry even in the presence of HVEM (178). 
The subsequent fusion of the viral envelope with the cell plasma membrane takes 
place at physiological pH and temperature in most cells (229), and requires the con-
certed action of three additional viral glycoproteins: gB, gH, and gL. Although the 
precise fusion mechanism is still elusive, the current model is that a homotrimer of gB 
and heterodimer of gH/gL comprise the core fusion machinery. The conformational 
switch in gD upon receptor binding brings gB and gH/gL together, and activates their 
fusion activities. Both gB and gH are fusogenic; they can act sequentially or they can 
form a complex (3, 200). 
As for the endocytic entry of HSV, the same glycoproteins (gB, gD, gH/gL) are 
required (142). A gD receptor is absolutely needed, but it is unclear whether it requires 
the same receptors as those involved in the direct fusion pathway. The mode of endo-
cytic uptake is cell-type specific and is not always clathrin-dependent. Actin rear-
rangement and RhoA GTPases are likely to be involved (26). In some cells, low pH is 
another critical trigger of fusion machinery in addition to receptor mediated activation 
(141). 
Translocation of the capsid to the nucleus 
After viral fusion, the tegument is the first to be exposed to the intracellular envi-
ronment. Most of the outer tegument proteins have been shown to dissociate from the 
capsid upon viral entry. This dissociation is likely induced by phosphorylation through 
virion associated and/or cellular kinases (127). Some of the released proteins provide 
important functions both early and late in infection. For example, the virion host shut-
off (VHS, UL41) protein remains in the cytoplasm to selectively degrade mRNA early 
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 in infection (52), whereas protein VP16 (UL48) is transported into the nucleus inde-
pendently of the capsid to act as immediate-early gene trans-inducing factor (αTIF), 
and later interacts with and blocks the pUL41 RNase activity (11, 190). 
As the majority of the tegument disassembles, the capsid then needs to be trans-
ported to the nucleus for genome replication and transcription. Diffusion alone may 
eventually allow delivery of the capsid to its destination. But the slow rate is clearly 
not compatible with the need for the capsid to travel long distances in human neurons. 
In this case, translocation becomes an active transport event. Studies have shown that 
dynein, a microtubule (MT)-based motor, is bound to capsids after entry, and these 
results prompted the theory that the incoming capsid is transported along the cellular 
microtubule network in a retrograde direction towards the nucleus (192). Other sup-
porting evidence includes the observation that movement of incoming viral particles 
was blocked by microtubule depolymerizing drugs (97, 206), or by over-expression of 
dynamitin, a protein disrupting the dynein complex (46). However, the HSV receptors 
for MT motors are not yet known. A series of non-essential tegument proteins and a 
potential dynein binding capsid protein, VP26 (UL35) (47), were tested for roles in 
incoming viral retrograde transport, but did not seem to actively participate. The 
tegument proteins pUL36 and pUL37 now emerge as candidates based on the fact that 
both proteins are associated with capsids as they traverse the cytosol to the nucleus 
(71, 111).  Moreover pUL36, but not pUL37, is required for the anterograde transport 
of capsids along microtubules during the egress phase of infection (112). 
When the capisd arrives in the nucleus, it docks at the nuclear pore complex 
(NPC). The attachment is importin-β dependent (144). Electron microscopy (EM) 
analyses support a mechanism in which the HSV-1 genome is rapidly and efficiently 
ejected from capsids bound to the nuclear pore complex, and empty capsids dissociate 
from the NPC after release of the genome (10, 113, 192). Experiments have also 
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 shown that the tegument protein VP1/2 (UL36) is critical in liberating the HSV-1 ge-
nome from the nucleocapsid. A temperature-sensitive mutation in the UL36 gene 
caused capsids to accumulate at nuclear pores, but they did not release their DNA at 
the non-permissive temperature. After a shift to the permissive temperature, the DNA 
was released successfully into the nucleus (10). Recently, the VP1/2 protein was 
shown to be proteolytically cleaved only after capsid binding to the NPC, and inhibi-
tion of this cleavage by protease inhibitors prevented the release of viral DNA (88). It 
is therefore proposed that the proteolytic cleavage of VP1/2 induced by binding to the 
NPC translates into structural changes in the capsid pentons on a particular vertex, 
which might be identical to the portal of DNA entry during capsid maturation and ge-
nome packaging (138). 
The transfer of the viral genome through the NPC channel also requires meta-
bolic energy (144). A study using atomic force microscopy (AFM) analyzed interac-
tions between HSV-1 capsid and the NPC; it revealed that the HSV-1 genome was de-
livered to the nucleus through the NPC central channel as a highly condensed, rod-like 
structure, and that translocation of the viral genome is associated with a remarkable 
widening of the NPC central channel (181). 
Viral gene expression 
Once viral DNA enters the host nucleus, it circularizes quickly without viral pro-
tein synthesis and prior to DNA replication (64, 81, 149). The DNA is circularized 
through joining of the genomic termini (199) by cellular DNA ligase IV and its cofac-
tor XRCC4.  This conclusion came from the observations that RNAi-mediated deple-
tion of either protein largely inhibited the formation of circular genomes and caused 
significant reduction of viral DNA synthesis (131). 
8 
 The viral genome is faced with an important "decision": whether to proceed to 
productive infection or to establish a latent infection (21). In the latent state, the viral 
genome is retained quiescently in the circular form as an episome associated with host 
nucleosomes; gene expression is repressed except for some non-encoding transcripts. 
In contrast, the lytic cycle is characterized by a progressive cascade of gene expression 
and DNA replication. In this case, the circular genome serves as a template for initial 
“θ” type replication followed by rolling circle replication (104). 
Viral gene expression during the productive infection is highly coordinated. In 
general, each viral gene has its own promoter and transcription is catalyzed by RNA 
polymerase II (pol II) of the infected host cell (30). All genes have been classified into 
three categories according to their transcriptional kinetics: α (immediate early, IE), β 
(early, E), and γ (late, L) genes.  
α genes are the first to be expressed, and are expressed optimally at approxi-
mately 2 to 4 hours post infection. Their promoters harbor multiple binding sites for 
cellular transcriptional factors, such as a TATA element, CAAT elements, and SP1 
binding sites (223). Their transcription does not require other de novo synthesized vi-
ral proteins, but are distinctively regulated by the tegument protein VP16 (UL48), 
which is translocated into the nucleus upon release of the tegument after viral entry. In 
the nucleus, VP16 forms a complex with host transcription factors Oct-1 and HCF 
(Host Cell Factor). Oct-1 specifically binds to the characteristic element TAATGA-
rAT in the upstream region of all α gene promoters, and enables VP16 to exert its 
transcriptional activation functions through promoting the formation of pol II preini-
tiation complexes on the promoters (114). 
α gene products include ICP0 (RL2), ICP4 (RS1), ICP22 (US1), ICP27 (UL54), 
ICP47 (US12) and US1.5. Excluding ICP47, the other five α proteins have been impli-
cated in stimulating β and γ gene expression. In particular, ICP4 is required for all 
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 post-α gene expression (27, 45), and its effect is exerted at the transcriptional level 
(68). ICP4 is also responsible for down regulation of α products including itself and 
ICP0. In this case, specific consensus binding sites appear to be responsible for ICP4 
mediated repression (66, 98). ICP0 is a nonspecific transactivator of α, β, and γ genes 
(170). It promotes viral infection and gene expression, especially at a low multiplicity 
of infection (MOI) where its absence leads to a 100 fold decrease in virus yield (187, 
198). The shut-off of α genes involves auto down regulation (e.g ICP4), and also re-
pression mediated by β and γ products (169). 
β genes produce proteins involved in viral DNA replication (219), such as a sin-
gle stranded DNA binding protein ICP8 (UL29) and viral DNA polymerse pUL30. The 
transcription of β genes starts at 3 hours post infection and reaches peak rates between 
4 to 8 hours post infection (169). Its activation requires at least the presence of func-
tional ICP4 but not viral DNA synthesis (223). Soon after the production of β proteins, 
viral DNA replication ensues. 
Efficient levels of γ gene transcription require α and β products including ICP4, 
ICP22, ICP27, and ICP8, and also the synthesis of viral DNA. γ genes predominantly 
encode proteins comprising the virion particle, and have been subdivided into two 
groups based on timing of expression and their dependence on viral DNA replication: 
The expression of γ1 (leaky-late) genes does not require accumulation of viral DNA 
synthesis whereas the expression of γ2 (true late) genes is entirely dependent on DNA 
replication (219). Typical γ1 products include the major capsid protein VP5, gB, and 
gD; and typical γ2 proteins include gC, pUL41 (VHS), and pUL36. 
DNA replication  
Once β proteins are expressed, several proteins localize to the nucleus where they 
assemble on the parental viral genome to promote DNA replication. The initial round 
10 
 of replication starts on the circular viral DNA molecule, creating a “θ” structure. At 
some point, the replication pattern switches to a rolling circle mechanism and pro-
duces head-to-tail concatemers of progeny DNA (82). Seven viral proteins are neces-
sary for viral DNA replication. These are the viral DNA polymerase (pUL30) (154) 
and its processivity factor (pUL42) (29), an origin binding protein (pUL9), the single 
stranded DNA binding protein (ICP8), and the helicase-primase complex of three pro-
teins, pUL5, pUL8, and pUL52 (22, 231). Host factors also participate in the replication 
event. For example, the host DNA polymerase α-primase, DNA ligase, and topoisom-
erase II are certainly required.  
There are three replication origins in the viral genome: oriS, a 45 bp palindromic 
sequence located in “c” sequences of the genome and present in two copies; and oriL, 
also a palindromic sequence of 144 bp mapped between the UL29 and UL30 genes (34, 
108, 224). However, only one origin is required for replication to occur (79, 151). The 
reason for the presence of three redundant replication origins is unclear. It may reflect 
the evolutionary history of the virus (169), and the oriL may be important for replica-
tion and reactivation from latency in certain types of tissue (7).  
The basic model for HSV genome replication proceeds as follows. First, UL9 pro-
tein binds to the origin sequences and unwinds the viral DNA by its helicase activity. 
ICP8 is then recruited by pUL9 and binds to the single stranded DNA of the unwound 
portion. Next, the remaining five proteins (pUL5, pUL8, pUL52, pUL30, and pUL42) 
are targeted to the origin by pUL9 and ICP8. They assemble into a helicase–primase 
complex and viral DNA polymerase complex to initiate “θ” form replication. The re-
action takes place at one or more origins and proceeds bidirectionally. Through an un-
known mechanism, replication switches from the “θ” form to a rolling circle form, and 
UL9 protein is no longer required for rolling circle replication; such replication is not 
origin dependent. The rolling circle replication generates long head-to-tail con-
11 
 catameric DNA complexes, which become cleaved into individual units during pack-
aging of viral DNA into progeny capsids (170). 
It is well known that the parental HSV genome and associated replication pro-
teins initially localize to sites adjacent to intranuclear structures containing compo-
nents of nuclear domain 10 (ND-10) (110, 213). It has been reported that the viral 
DNA replication origins promoted the localization of viral genome to the ND-10 do-
mains (193), suggesting viral DNA replication proteins may play a role in targeting 
viral DNA to the ND-10 structures. Alternatively, it has been shown by a more recent 
study that ND-10 proteins localized to viral genomes, rather than vice versa (53).  
Thus, viral DNA and replication proteins initially localize to other intranuclear sites 
and induce redistribution of pre-existing ND-10 proteins leading to formation of novel 
ND-10 bodies located at sites containing viral genomes.  
HSV genome replication initiates at punctate ICP8 foci near the ND-10-like 
structures (116), and these foci are named “pre-replicative sites”. As DNA replication 
progresses, the pre-replicative sites expand and coalesce to form replication compart-
ments (33, 193, 203) that eventually fill the nucleus. At this point, replication takes 
place in “replication compartments” that consist of accumulating DNA molecules and 
replication complexes (158). It has been reported that this compartmentalization of 
viral proteins is necessary for efficient viral DNA replication as well as late gene tran-
scription (121). 
Capsid assembly 
After the onset of viral DNA replication, the γ genes are transcribed, including 
those that encode viral capsid proteins. In the nucleus, these proteins assemble into 
closed shells with an internal scaffold; viral DNA is then inserted into the capsids and 
the internal scaffold is expelled giving rise to a mature nucleocapsid. In the infected 
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 nucleus, there are four types of capsids with morphological differences that can be dis-
tinguished by electron microscopy (EM): procapsids and type A-, B-, and C-capsids 
(134). Although the procapsid contains an internal scaffold, it is morphologically dis-
tinct from all other capsids because of its porous and roughly spherical appearance 
(134, 208). A-, B- and C-capsids share a common angularized icosahedral structure of 
approximately 120 nm in diameter. A-capsids contain only an icosaheral shell without 
the scaffold. B-capsids contain a spherical internal scaffold but no DNA. The C-capsid 
is the mature nucleocapsid; it contains DNA and lacks the scaffold (16, 179, 241). 
The procapsid has been widely accepted as the precursor of all capsid types; its 
formation requires interactions of the major capsid protein VP5 (UL19), triplex pro-
teins VP19C (UL38) and VP23 (UL18), and a scaffold protein VP22a (UL26.5) (39, 
135, 136). Although the final assembly occurs in the nucleus, some initial interactions 
take place in the cytoplasm (140, 165). VP5, VP23, and the hexon outer tip protein 
VP26 are not capable of nuclear localization on their own. However, VP5 can be 
transported into the nucleus by the triplex protein VP19C and/or by the uncleaved pre-
cursor form of scaffold protein VP22a, pre-VP22a. VP23 nuclear localization is 
VP19C dependent, while VP26 nuclear import requires the presence of both VP5 and 
VP19C or pre-VP22a (140, 165). Once in the nucleus, VP5/pre-VP22a complexes 
come together as a result of self assembly of pre-VP22a. The triplex proteins VP19C 
and VP23 are then added to form a partial capsid. As hexons and pentons are added, 
the structure assembles into a round procapsid (134). In the procapsid, the internal 
scaffold is composed of many copies of the pre-VP22a protein encoded by UL26.5 
gene, and another unprocessed protein encoded by UL26. The UL26.5 transcript initi-
ates within the UL26 gene and is in the same coding frame. As a result, the UL26 pro-
tein shares its C-terminal sequence with pUL26.5 (i.e. pre-VP22a). It is this C-terminal 
domain that mediates the interactions with VP5 and leads to incorporation of the scaf-
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 fold proteins into the capsid structure during assembly (37, 78, 221). Uniquely, the 
pUL26 possesses an N-terminus with intrinsic protease activity. Upon activation, it 
cleaves itself at two sites and produces two functional units, a serine protease VP24 
and a scaffold protein VP21; it also cleaves pre-VP22a into VP22a (148, 222). The 
procapsid undergoes a structural transformation and becomes polyhedral around the 
time that the internal scaffold proteins are cleaved (25, 183). The protease activity is 
required for capsid assembly (63), and its role is presumably to release the capsid shell 
from constraints that preclude maturation into more angualrized capsid forms. A do-
decamer of UL6 proteins is also assembled onto the procapsid through interactions 
with pUL26.5 to form a portal structure that is required for DNA packaging (133, 139, 
147). 
In the current view, A-, B- and C-capsids are considered to be three different out-
comes of the procapsid maturation pathway. A-capsids arise when DNA is not inserted 
or not retained but the internal scaffold is lost or degraded. B-capsids arise as DNA is 
not inserted and the internal scaffold is trapped within the capsid. C-capsids are the 
only capsids to contain properly packaged with DNA; their internal scaffold is re-
leased and the DNA is sealed inside by the conformational changes in the capsid shell. 
DNA packaging 
Encapsidation of HSV DNA is a process in which cleavage of unit length viral 
genomes from concatamers is tightly coupled to their packaging into preformed cap-
sids. It has been observed that viral DNA cleavage does not occur in cells infected 
with viruses that fail to produce capsids, suggesting that capsids contain essential parts 
of the cleavage/packaging machinery (36).  
The cleavage and packaging machinery is complex and requires seven viral pro-
teins pUL6, pUL15, pUL17, pUL25, pUL28, pUL32, and pUL33 (5, 170). They interact 
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 with the capsid either during capsid assembly or in the course of DNA packaging (5). 
As described above, viral DNA is believed to enter the capsid through a ring-shaped 
portal formed by 12 copies of UL6 protein located at one vertex of the capsid (137).  
By analogy with bacteriophage DNA packaging systems, the terminase complex 
comprising pUL15, pUL28 and pUL33 drives the HSV genome into the capsid with en-
ergy provided by ATPase activity. The terminase also functions to cleave the con-
catemeric DNA to yield a monomeric genome. Supporting evidence for this proposi-
tion includes sequence similarity between pUL15 and the large subunit of bacterio-
phage T4 terminase, the ability of pUL28 to bind to the viral DNA packaging signals, 
and the interaction of pUL15 and pUL28 with the portal protein pUL6 (2, 32, 225, 237). 
Within the complex, direct interactions have been characterized between pUL15 and 
pUL28, and also between pUL28 and pUL33, but not between pUL15 and pUL33 (1, 12, 
83, 95, 96, 233). A recent study suggested that the three proteins assemble in the cyto-
plasm and are transported into the nucleus by the nuclear localization signal (NLS) of 
pUL15 (234). 
The final step of DNA packaging is “capsid completion”. This term refers to the 
formation of a stable DNA-containing capsid. Earlier studies have indicated that the 
UL25 protein of HSV-1 is not required for cleavage of newly replicated viral DNA but 
is necessary for stable encapsidation. It was suggested that pUL25 may function as a 
head completion protein or plug which seals the portal channel after DNA packaging 
(120). pUL25 has also been reported to interact with the capsid shell and viral DNA, 
further suggesting a role in anchoring of the genome to the capsid (143). The addition 
of pUL25 to the capsid is proposed to occur in response to the release of the internal 
capsid proteins (182). 
The functions of pUL17 and pUL32 are less well defined. The infection of UL17 
or UL33 null HSV-1 mutant shows a common phenotype: newly replicated concate-
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 meric DNA is not cleaved into unit-length genomes, and, accordingly, in infected cell 
nuclei no C capsids are detectable while scaffold-containing B capsids accumulate and 
mislocalize (101, 176, 202). These observations have suggested pUL17 and pUL32 are 
involved in properly targeting capsids to viral DNA replication compartments for en-
capsidation. More light has been cast recently on pUL17 with the finding that pUL17 
appears to bind to pUL25 on C-capsids, thus implying a role in stabilizing the capsid-
DNA structure (204, 210). 
The cleavage of viral DNA also needs cis-acting elements in the viral genome. 
Two signal segments designated pac1 and pac2 in the “a” sequence define the cleav-
age sites (35, 191, 216). It is proposed that the packaging complex binds to the DNA 
concatemer and scans for the first pac2 site in proper orientation. Cleavage occurs at a 
fixed distance from pac2, generating the L end of one genome that is inserted into the 
capsid. As the DNA engagement continues, the complex keeps scanning the following 
DNA until a directly repeated junction is encountered. Then a second cleavage is exe-
cuted to produces a monomeric genome. 
Viral egress 
After the viral genome is packaged, nucleocapsids exit the nucleus, become en-
veloped virions in cytoplasm, and eventually gain access to the extracellular space. 
Enveloped capsids have been observed in the perinuclear space between the inner and 
outer nuclear membrane (INM and ONM, respectively), and this led to two proposed 
models of viral egress. The first model (Fig 1.2), also called the “double envelopment” 
pathway, proposed that nucleocapsids are enveloped at the INM, become de-
enveloped by fusion of the virion envelope with the ONM, and then undergo secon-
dary envelopment at cytoplasmic membranes. These virions are transported in vesicles 
to the plasma membrane and are released into the extracellular space through fusion 
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 between the vesicle membrane and plasma membrane (51, 123). In the second model, 
known as the “single nuclear envelopment” pathway, the capsids acquire the initial 
envelope at the INM, enter into a vesicle at the ONM, and retain their primary and fi-
nal envelope as they leave the cell through the secretory pathway (19, 86). In this 
model, virion glycoproteins are modified in transit to the plasma membrane and peri-
nuclear virions should contain the entire complement of tegument and envelope pro-
teins present on mature extra-cellular virions. However, this model is inconsistent with 
multiple lines of evidence. First, according to electron microscopic examinations, the 
primary envelope and primary tegument in perinuclear virions clearly differ in ultra-
structure from the final envelope and tegument in cytoplasmic and extracellular viri-
ons (67, 70). Second, biochemical studies revealed compositional differences between 
perinuclear virions and extracellular virions. In an HSV-1 mutant, when gD was re-
tained in the endoplasmic reticulum (ER), gD was detected on the perinuclear virions 
but was absent from extracellular virions (188). Moreover, pUL34 and pUL31 are 
components of perinuclear virions, but are missing in extracellular ones (163), 
whereas the major tegument protein pUL49 is associated with cytoplasmic and ex-
tracellular virions but not with perinuclear particles (94). Moreover, the phospholipid 
composition differs between the envelope of extracellular HSV-1 virions and the host 
cell nuclear membrane (214). All of these differences can only be explained by the 
two-step envelopment model. 
Alternatively, a third model was suggested by a recent report. Wild et al. ob-
served that, in bovine herpesvirus-1 infected cells, nuclear pores were dilated to a size 
readily allowing capsids to pass through (228); and so they proposed that virus exits 
the cell via a “dual pathway single envelopment” model (105). In this model, a minor
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Figure 1.2 Diagram of herpesvirus egress pathway [reprinted from refer-
ence (125)]. In the nucleus capsids assemble around a scaffold (1 – 3), then 
DNA is packaged (4) into preformed capsids. DNA-filled capsids (5) contact the 
inner nuclear membrane at the sites where the nuclear lamina has been locally 
dismantled (6), bud into perinuclear space resulting in enveloped primary virions 
(7). The primary envelope fuses with the outer nuclear membrane (8), releasing 
the nucleocapsid into the cytosol where capsid-proximal tegument proteins as-
semble onto the capsid (9). Concurrently at the trans-Golgi apparatus, glycopro-
teins and outer tegument proteins assemble together (10). Two subassemblies 
join to complete the final envelopment (11) and the mature virion is then trans-
ported in a vesicle (12) to the plasma membrane for release (13). (10a – 13a) 
Formation and release of capsid-free particles.  
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 population of capsids egress via a “single nuclear envelopment” pathway early in in-
fection, whereas the majority exit the nucleus through enlarged nuclear pores, become 
enveloped in the cytoplasm and are released by secretory vesicles. At face value, this 
model could also be compatible with the above results supporting the “double envel-
opment” model. Nevertheless, it faces challenges that have not been resolved at this 
time. For instance, an HSV-1 defective in US3 kinase induced accumulation of envel-
oped virions in the perinuclear space and slowed viral production, indicating at least 
capsid budding into the perinuclear space is not a minor egress pathway (174). 
Nuclear egress 
HSV nuclear egress is a complex process, involving interactions of viral proteins 
and cellular components. Nucleocapsids initiate the event by budding at the inner nu-
clear membrane (INM), acquire INM-derived envelope (specified as the primary enve-
lope), and translocate into the perinuclear space. De-envelopment occurs when the 
primary envelope fuses with the outer nuclear membrane (ONM); capsids are then re-
leased into cytoplasm. 
Primary envelopment at the INM 
It is believed that DNA packaging is a prerequisite for nuclear egress of capsids. 
In wild type virus infections, a preference has been noted for primary envelopment of 
C-capsids over other non-DNA-containing capsid forms. The mechanism underlying 
this preferential envelopment of C capsids is unclear. In an early study, the conserved 
capsid-associated protein pUL25 was suggested to play a role in this process (197); 
more recently, the pUL25 homolog in pseudorabies virus was found to be necessary 
for the nuclear egress of capsids (92). However, no capsid nor capsid-associated pro-
tein has been identified so far that physically interacts with the egress complex 
(pUL31/pUL34) to drive primary envelopment. DNA-filled capsids move from in-
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 tranuclear assembly sites to contact the inner nuclear membrane prior to primary en-
velopment. This intranuclear transport of HSV-1 capsids appears to be actin depend-
ent, inasmuch as it could be inhibited by latrunculin B (60). This is additionally sup-
ported by the finding of actin filaments in the host cell nucleus induced by HSV-1 in-
fection (58). 
Two HSV-1 proteins, pUL31 and pUL34 are required to initiate the primary en-
velopment at the INM (163). Analysis of UL31 and UL34 deletion mutants has indi-
cated that the absence of either protein results in a drastic impairment in primary en-
velopment with capsids trapped within the nucleus (24, 62, 94, 163, 173). The UL34 or 
UL31 null viruses failed to replicate on most non-complementing cell lines. An excep-
tion is that rabbit skin cells were permissive to UL31 null virus to a limited extent 
(107). 
pUL31 and pUL34 are highly conserved in the herpesviridae family. pUL34 is 
predicted to be a type II integral membrane protein with a 22 amino acid transmem-
brane domain at the C-terminus (157, 173, 184), while pUL31 is a nuclear phosphopro-
tein (23). In wild type virus infected cells, pUL31 and pUL34 co-localize on the nu-
clear rim. In the absence of pUL34, pUL31 is exclusively intranuclear, whereas without 
pUL31, pUL34 redistributes to the ER, although the protein appears to possess an in-
trinsic nuclear targeting signal (94, 163). Physical interaction between the two proteins 
has been demonstrated; and a 50 amino acid region of pUL34 is known as an essential 
domain interacting with pUL31 (106). It is very clear that the complex formation of 
two proteins is important for proper positioning of both partners at the inner nuclear 
membrane, which is a prerequisite for primary envelopment (163). Both proteins are 
incorporated into the perinuclear virions, but are likely lost at the ONM through de-
envelopment (164). 
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 The pUL31/pUL34 complex is considered to act as a membrane receptor for cap-
sids to recognize, bind, and then bud into the perinuclear space. However, it is unclear 
whether additional viral or cellular proteins are required in this process. In an in vitro 
system, reconstruction of nuclear egress required cytosol, whereas infected cytosol 
was not necessary (160). This data strongly implied involvement of host factors. In 
another study, co-expression of pUL31 and pUL34 induced vesicles to form from the 
INM in the absence of viral infection; those vesicles resembled primary envelopes 
without a nucleocapsid (91). This also argues for the contribution of cellular factors in 
the budding reaction. Such factors might be recruited from their natural cytoplasmic 
location, or were previously unrecognized in the nucleus.  
Alteration of the nuclear lamina has been observed after HSV infection and may 
be required so that the inner nuclear membrane is accessible to capsids (103, 162, 
180). Multiple lines of evidence indicate that pUL31 and pUL34 play a role in lamina 
modification. Over expression of pUL31 alone was sufficient to relocalize lamin A/C 
from the nuclear rim into nucleoplasmic aggregates, whereas over-expression of 
pUL34 causes some lamin A/C redistribution into the cytoplasm (162). More impor-
tantly, both pUL31 and pUL34 are able to directly bind lamins A/C and/or B, suggest-
ing that pUL31 and pUL34 modify the conformation of the nuclear lamina in infected 
cells, possibly by direct interaction with lamin proteins (69, 162). Given that the nu-
clear lamina potentially excludes nucleocapsids from envelopment sites at the inner 
nuclear membrane, the lamina alteration may reflect a role of the pUL31/pUL34 pro-
tein complex in perturbing the lamina to promote nucleocapsid egress from the nu-
cleus. Lamins A/C and B appear to participate in viral infection in different ways; their 
respective roles are covered in more detail in Chapter III, 
In addition, the complex can also recruit protein kinases to modify the lamina. 
Cellular protein kinase C (PKC) is enriched on the nuclear rim in a pUL31/pUL34-
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 dependent manner, which in turn phosphorylates lamins A/C and/or B (130, 146). This 
could result in local dismantling of the lamina network and the underlying chromatin 
layer (185), enabling the capsids to access the inner nuclear membrane. Viral encoded 
kinases are also involved in this process. The UL13 kinase of human cytomegalovirus 
(HCMV) is targeted to the lamin B receptor via interaction with cellular protein p32, 
causing redistribution of lamins A/C and B (115). In a pUL34-dependent manner, 
HSV-1 US3 kinase hyperphosphorylates emerin, a lamin-interacting nuclear mem-
brane protein, and induces localizational changes of this protein (103). This kinase has 
also been found to phosphorylate lamin A/C during infection, as reported in Chapter 
II. Transient expression of pUS3 alone is sufficient to disrupt the nuclear lamina (15).  
The US3 kinase also assists pUL31/pUL34 in proper positioning, and is needed for 
efficient nuclear egress. Deletion or deactivation of the kinase induces aggregation of 
pUL31/pUL34 on the nuclear rim in infected cells, and results in a delay in viral pro-
duction, but has little effect on the final peak yield of infectious virus (164, 174). Elec-
tron microscopic examinations of cells infected by a US3-defective HSV mutant have 
revealed perinuclear virions that accumulate in invaginations of the inner nuclear 
membrane (164, 174). These structures are assumed to form as a result of delayed per-
inuclear virion de-envelopment, and they appear to cause restriction of nucleocapsid 
envelopment to certain sites within the inner nuclear membrane. Therefore, US3 kinase 
activity modulates pUL31/pUL34 distribution in the nuclear membrane as well as the 
fusion of the primary envelope with the outer nuclear membrane. 
pUS3 is a PKA-like serine/threonine kinase (14, 155). Interestingly, both pUL31 
and pUL34 are phosphorylated by pUS3 in vivo (89, 156). Although the catalytic rela-
tionship between pUS3 and pUL34 has been examined in details, the phosphorylation 
of pUL34 is not demonstrably important to nuclear egress (174). Instead, I show in 
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 Chapter IV that pUL31 is a functionally important downstream effecter of the US3 
kinase. 
De-envelopment at the ONM 
Several glycoproteins have been identified as components of the perinuclear 
virion, including gD, gB and gM (6, 188, 195, 207). It is reasonable to assume that the 
fusion of the primary envelope with the ONM is conducted by the same set of glyco-
proteins involved in entry and other fusion events. In earlier studies, however, deletion 
of these major glycoproteins required in other membrane fusion did not affect the de-
envelopment process (18, 70, 84). The core fusion machinery of the perinuclear virion 
has been elusive. Recently, an HSV-1 mutant lacking both gB and gH produced a 
large number of perinuclear virions, indicating a failure of de-envelopment, whereas a 
single deletion of either gene had no detectable effect on the de-envelopment process 
(56). This observation indicates that fusion relevant to nuclear egress requires both gB 
and gH, and these proteins function in a redundant manner. It also suggests that fusion 
during nuclear egress is mechanistically different from that of viral entry, because in 
the latter, both gB and gH are required and are not functionally redundant. 
Tegumentation in the cytoplasm  
After translocation into the cytoplasm, capsids undergo tegumentation and sec-
ondary envelopment through a highly ordered network of protein-protein interactions. 
The tegument proteins interact with the capsid on one side and with the viral envelope 
proteins on the other in order to link the structural components to the final envelope of 
the HSV-1 virion and to secure the integrity of the virus particle (123). It has become 
clear that final tegumentation can initiate at two different sites, the capsid and the fu-
ture envelope, resulting in two “subassemblies” that combine to produce a mature 
virion (125). 
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 The first layer of tegument around the capsid is composed of pUL36 and pUL37. 
pUL36 has been shown to interact with the major capsid protein VP5 (139, 238), 
whereas pUL37 is likely incorporated via interaction with pUL36 (90). pUL36 and 
pUL37 are the only tegument components conserved in the Herpesviridae family. The 
absence of pUL36 and pUL37 abolishes virus maturation (38, 40). The level of these 
proteins in the virion is strictly controlled, whereas stoichiometry of outer tegument 
proteins can vary extensively (126). As mentioned in a previous section, pUL36 and 
pUL37 remain associated with incoming capsids while outer tegument proteins dis-
perse after viral entry (71, 111), and are involved in intracytoplasmic transport of cap-
sids during entry and exit (112, 230). Besides these conserved components, other non-
conserved proteins might also be components of the inner tegument. For instance, 
pUS3 is also encompassed in the capsid-proximal tegument.  
Concurrently, at the final envelopment site in the trans-Golgi network, another 
subset of tegument proteins including pUL46, pUL47 and pUL49, are assembled to-
gether with viral glycoproteins (211). Viral glycoproteins are recruited to cytoplasmic 
envelopment sites by an envelope protein gM, which is also thought to retain other 
glycoproteins at the envelopment site, or to retrieve them from the cell surface (31). 
Tegument proteins may also be recruited by a small myristoylated protein pUL11, 
which has intrinsic targeting properties to the Golgi apparatus (17, 109).  
The capsids coated with pUL36 and pUL37 are then transported to the cytoplas-
mic envelopment site where the remaining tegument and envelope glycoproteins await 
them. Although it is not yet clear which proteins form the bridge between the two sub-
assemblies, some experiments indicate that pUL48 (VP16) may play a role in this 
process (62, 218). pUL48 has been shown to interact with tegument proteins pUL49 
and pUL41 (VHS) (189). Mutant forms of pUL41 that do not bind pUL48 fail to be-
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 come incorporated into the virion (159). Cross-linking studies have indicated interac-
tions between pUL48 and gB, gD, and gH (242). 
Secondary Envelopment and release 
Following tegumentation, HSV-1 capsids bud into cytoplasmic vesicles derived 
from the trans-Golgi Network (TGN) or endosomes by wrapping the membranous cis-
terna around the capsid to form a mature herpesvirus particle within a cellular vesicle. 
This vesicle is then transported to the plasma membrane. After fusion of the vesicle 
and plasma membrane, the nascent virion is released into the extracellular space.  
Studies of viral mutants have shed light on the roles of certain viral envelope pro-
teins in this event. As revealed by EM, HSV-1 mutants lacking either UL20 or gK pro-
duced dramatic accumulations of un-enveloped and aberrantly enveloped capsids in 
the cytoplasm with a marked absence of extra-cellular virion (61, 84). A triple mutant 
lacking gD, gE, and gI had a severe defect in the final envelopment step. It is proposed 
that gD and the gE/gI heterodimeric complex act in a redundant fashion to anchor the 
virion envelope onto tegumented capsids (54). In contrast, it is also possible that dele-
tion of multiple glycoproteins indirectly disrupts the integrity of many different pro-
tein protein interactions required for the final envelopment step and that the resulting 
phenotype results from the compound effects of an abnormal glycoprotein profile. 
Secondary envelopment does not require the presence of capsids. Capsid-free 
particles can be formed by enclosing tegument proteins in an envelope in a process 
mimicking normal capsid envelopment (119, 166). These structures are called light (L) 
particles. These particles form in abundance in cells infected with particular mutant 
viruses, in which normal capsid assembly and tegument formation is inhibited (119, 
166). This demonstrates that capsids are not required to trigger secondary envelop-
ment. It has been proposed that normal tegumentation requires pUL36 and pUL37 in-
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 teractions with the capsid and that pUL49 may be required for proper interactions with 
viral glycoproteins in the final envelopment step (123). In the absence of capsids, 
tegument assembly could be mediated through UL49 anchoring, resulting in the forma-
tion of L particles. 
The release of nascent virions following final envelopment mimics the cellular 
secretory pathway. Viral proteins are apparently involved, although their functions in 
this particular step remain elusive. It is also known that the late stages in viral egress 
may differ depending on the cell type (85, 125). For example, in polarized epithelial 
cells, wild type virions are sorted predominantly to cell junctions, whereas gE/gI null 
virions are released nonspecifically into the extracellular space (44). 
Cell-cell spread 
Dissemination of HSV occurs via both the release of progeny viruses into the ex-
tracellular environment and direct cell-to-cell spread. In the process of cell-cell spread, 
nascent virions are targeted to cell junctions that contact neighboring cells. These viri-
ons are then released and bound immediately by the adjacent cell for internalization 
(85). In the host, HSV disseminate mostly by spreading from cell to cell. This strategy 
is expected to enhance viral spread and enable viruses to avoid host immune defenses. 
The glycoproteins that are required for HSV cell-cell spread are gB, gD, gH/gL 
and gE/gI (85). The requirements for gD and its receptor as well as gB and gH/gL 
parallel those involved in entry of cell free virions. gE and gI, although not required 
for entry of cell free virions, are important in promoting HSV cell-cell spread (150, 
175). Viruses lacking gE or gI cause no disease in rodents and produce smaller 
plaques in culture compared to wild type virus (43). Subsequent studies showed that 
gE/gI is involved in routing virions to the basolateral surfaces of polarized cells (55, 
87). It is proposed that gE/gI is concentrated at cell junctions through interaction with 
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 an as-yet-unidentified extracelluar ligand, and so diverts viral trafficking from apical 
to basolateral membranes (150). Moreover, the enrichment of nectins at junctions of 
neurons and epithelial cells, coupled with the ability of gD to bind them, suggests an 
alternative mechanism by which virions are directed towards the neuronal terminal 
(85). 
In addition, cells infected by HSV-1 or PRV can form extended protrusions to 
contact neighboring cells and deliver virions to the contacted cell (57, 100, 215). 
These F actin-associated structures can be induced by US3 kinase in PRV and can be 
reproduced by inhibition of the Rho-associated kinase (ROCK) when pUS3 is absent 
(57). 
Brief outline of dissertation research 
The goal of the work herein was to shed some light on the machinery of HSV nu-
clear egress. With the proposal that viral US3 kinase phosphotylates viral and/or cellu-
lar fators to regulate the capsid primary envelopment at the INM and subsequent de-
envelopment at the ONM, several putative substrates of pUS3 were identified and the 
functional relevance of their catalytic relationships was evaluated. In Chapter II, the 
distribution of lamin A/C was observed to be modified by pUS3 kinase activity, and 
lamin A/C was identified as a substrate of the kinase. Therefore I hypothesized that 
lamin A/C might be the factor required for pUS3 functions. However, this hypotheis 
was not favored by the data shown in Chapter III, where I examined the respective 
roles of lamin A/C and lamin B1 during viral infection. Finally, in Chapter IV, I de-
termined that pUL31 is a major substrate mediating pUS3 regulatory effects, and found 
the phosphorylation of pUL31 to be a dynamic event during nuclear egress. 
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 Abstract 
The herpes simplex virus type 1 (HSV-1) US3 gene encodes a serine/threonine 
kinase that, when inactivated, causes capsids to aggregate aberrantly between the inner 
and outer nuclear membranes (INM and ONM, respectively) within evagina-
tions/extensions of the perinuclear space. In both Hep2 cells and an engineered cell 
line derived from Hep2 cells expressing lamin A/C fused to enhanced green fluores-
cent protein (eGFP-lamin A/C), lamin A/C localized mostly in a reticular pattern with 
small regions of the INM devoid of eGFP-lamin A/C when they were either mock in-
fected or infected with wild-type HSV-1(F). Cells infected with HSV-1(F) also con-
tained some larger diffuse regions lacking lamin A/C. Proteins UL31 and UL34, mark-
ers of potential envelopment sites at the INM and perinuclear virions, localized within 
the regions devoid of lamin A/C and also in regions containing lamin A/C. Similar to 
previous observations with Vero cells (S. L. Bjerke and R. J. Roller, Virology 
347:261-276, 2006), the proteins UL34 and UL31 localized exclusively in very discrete 
regions of the nuclear lamina lacking lamin A/C in the absence of US3 kinase activity. 
To determine how US3 alters lamin A/C distribution, US3 was purified and shown to 
phosphorylate lamin A/C at multiple sites in vitro, despite the presence of only one 
putative US3 kinase consensus site in the lamin A/C sequence. US3 kinase activity was 
also sufficient to invoke partial solubilization of lamin A/C from permeabilized Hep2 
cell nuclei in an ATP-dependent manner. Two-dimensional electrophoretic analyses of 
lamin A/C revealed that lamin A/C is phosphorylated in HSV-infected cells, and the 
full spectrum of phosphorylation requires US3 kinase activity. These data suggest that 
US3 kinase activity regulates HSV-1 capsid nuclear egress at least in part by phos-
phorylation of lamin A/C. 
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 Introduction 
Like orthologues in other members of the subfamily Alphaherpesvirinae, the US3 
gene of herpes simplex virus type 1 (HSV-1) encodes a serine/threonine kinase (60, 
160). These proteins have been implicated in nuclear egress, prevention of apoptosis, 
and modulation of the actin cytoskeleton to promote the cell-to-cell spread of virions 
(55, 63, 85, 94, 107, 170, 176, 183, 220). The current study focuses on the role of the 
US3 gene-encoded kinase activity in nuclear egress of nucleocapsids and virions.  
Although models of HSV virion egress differ as to the extent of its contribution, 
all models propose that at some point during the course of infection with wild-type 
herpesviruses, nucleocapsids assemble in the nucleoplasm and bud through the inner 
nuclear membrane (INM) and into the perinuclear space (87, 199, 226). This com-
partment is delimited by the INM and outer nuclear membrane (ONM) and is continu-
ous with the lumen of the endoplasmic reticulum. To become enveloped, capsids must 
bypass the nuclear lamina, a fibrous meshwork lining the nucleoplasmic face of the 
INM. The nuclear lamina provides structural rigidity to the nucleus and is essential for 
transcription and DNA replication (73, 189). The lamina contains a series of type 5 
intermediate filaments composed of lamin types A, B1, B2, and C; types A and C are 
products of RNA splice variants from the Lmna transcript, whereas types B1 and B2 
are derived from other genes (57, 76, 77). Like all intermediate filaments, lamins 
comprise globular head and tail domains that flank a rod domain (59). The rod do-
mains of two lamins intertwine to form protomers, whereas regions bordering the 
rod/head and rod/tail domains likely interact with other lamin protomers to form 
longer filaments (162). The globular domains interact with a variety of proteins in the 
lamina and INM.  
One remarkable feature of the lamina is its dynamic nature. The lamina expands 
by the addition of protomers during interphase, is completely disassembled prior to 
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 mitosis, and is partially disrupted during apoptosis. Phosphorylation likely plays a role 
in lamin dynamics in all phases of the cell cycle. The disassembly of the lamina during 
mitosis is associated with phosphorylation of lamin A/C by cdc2 kinase at Ser390 and 
Ser392 and during apoptosis by protein kinase C (PKC) delta (26, 30, 46, 150, 151). 
Protein kinase C can phosphorylate lamin A/C at Ser572 in vitro (48).  
The architecture of the nuclear lamina is altered from its normal state during 
HSV-1 infection (13, 147, 168, 184, 190). Depending on the cell line and time after 
infection, these changes include (i) limited displacement and conformational changes 
of lamin A/C (13, 168, 190), (ii) redistribution of lamin B to a perinuclear region (147, 
184), and (iii) increased mobility and mislocalization of lamin B receptor, one of sev-
eral integral membrane proteins that anchor the nuclear lamina to the INM (184, 189). 
In attempts to understand the mechanism(s) by which the lamina becomes displaced, it 
was found that PKC of the alpha and delta subfamilies are recruited to the nuclear rim 
of HSV-1-infected cells and that lamin B becomes hyperphosphorylated during HSV 
infection, in part due to phosphorylation by PKC (146). Given these observations, it 
was postulated that HSV coopts cellular mechanisms to disrupt the nuclear lamina and 
thereby promotes egress of nucleocapsids (146). The state of phosphorylation of lamin 
A/C in HSV-infected cells is unknown, in contrast to that of lamin B. Previous analy-
ses using one-dimensional gel electrophoresis indicated that HSV infection did not 
drastically alter the electrophoretic mobility of lamin A/C from human foreskin fibro-
blasts or from Hep2 cells, suggesting that phosphorylation is not extensive(164, 168).  
As detected by immunoelectron microscopy, nascent virions located in the peri-
nuclear space contain the US3 kinase and at least two of its substrates, the proteins en-
coded by the UL31 and UL34 genes (as products pUL31 and pUL34, respectively) (90, 
156, 161, 170). The proteins pUL31 and pUL34 are required for efficient envelopment 
of nucleocapsids at the INM (22, 110, 169, 175). The observations that proteins pUS3, 
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 pUL31, and pUL34 are located within perinuclear virions and at the INM suggest that 
these proteins are incorporated into the virion during budding at the INM (164). Inter-
estingly, all of the HSV-1-induced alterations in lamin A and B distribu-
tion/conformation require expression of pUL31 and pUL34 (13, 147, 168, 191). How 
pUL31 and pUL34 alter the structure of the nuclear lamina is not known, but the altera-
tion likely involves multiple mechanisms. For example, both pUL31 and pUL34 are 
required for the recruitment of protein kinase C alpha and delta to the nuclear rim, and 
both can interact with lamin A/C in vitro (147, 168). Thus, UL31/UL34 might interrupt 
the nuclear lamina by mechanical interference with lamin-lamin interactions, by a dis-
ruption of lamin folding, by recruitment of lamina-disrupting kinases, or by all three 
mechanisms.  
Deletion of US3 delays the onset of production of infectious virus and reduces 
peak infectious titers by approximately 10- to 30-fold with Hep2 cells (170, 176). The 
absence of US3 or its kinase activity does not preclude budding at the INM, nor incor-
poration of the pUL31/pUL34 into perinuclear virions, but causes these virions to ag-
gregate aberrantly within the perinuclear space (94, 170, 176, 183, 220). These obser-
vations with both the HSV and the pseudorabies herpesvirus (PRV) systems have led 
to the conclusion that US3 is involved in the exit of virions from the perinuclear space 
into the cytoplasm (94, 170). On the other hand, if the exit from the perinuclear space 
was the sole contribution of US3 to nuclear egress, one might expect that pUS3(–) per-
inuclear virions would distribute evenly throughout the perinuclear space, but this is 
not the case. Rather, virions are tightly packed together within discrete invagina-
tions/extensions of the nuclear membrane (NM). How US3 kinase activity precludes 
this aberrant aggregation of perinuclear virions is unknown.  
In vitro biochemical studies characterized a US3 kinase minimal consensus se-
quence as (R)n-X-(S/T)-Y-Y, where n is >2, S/T is the target site where either serine 
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 or threonine is phosphorylated, X can be absent or any amino acid but preferably Arg, 
Ala, Val, Pro, or Ser, and Y is similar to X except that it cannot be an absent amino 
acid, proline, or an acidic residue (105, 158, 159). The optimal consensus sequence is 
similar except that X is not absent and n is 3. Both pUL34 and pUL31 have one or 
more sequences matching this consensus motif (117). Of the known US3 kinase sub-
strates localizing at the NM, the lack of phosphorylation of pUL34 is not likely respon-
sible for the aberrant NM morphology in US3 mutant-infected cells (174), whereas the 
role of pUL31 phosphorylation has not yet been tested. The current studies were initi-
ated under the hypothesis that substrates in addition to pUL31 and pUL34 may be in-
volved in capsid and virion egress from the NM. 
Materials and methods 
Cells and viruses. Wild-type HSV-1(F) virus and a US3 deletion mutant virus, 
R7041, have been described and were obtained from B. Roizman (48, 160). Virus 
vRR1204, containing a mutation at US3 codon 220 changing lysine to alanine 
(K220A) in an HSV-1(F) background, was a kind gift of R. J. Roller (174). The vi-
ruses were grown and titers were determined on Vero cells as described previously 
(132).  
An enhanced green fluorescent protein (eGFP)-lamin A/C-expressing cell line 
was made by transfection of DNA containing a cDNA of Lmna fused to eGFP-C1 and 
encoding neomycin resistance (a kind gift from D. Gilbert, Upstate Medical Center) 
into human Hep2 cells (80). Individual eGFP-positive cells were sorted based on the 
intensity of fluorescence determined using an ExCalibur fluorescence-activated cell 
sorter (FACS), into individual wells of a 96-well plate. The cells were grown in 
growth medium (Dulbecco's minimal essential medium supplemented with 10% fetal 
bovine serum and antibiotics) supplemented with 250 µg/ml Geneticin (Invitrogen). 
33 
 The highest-expression cells failed to expand further, whereas some intermediate ex-
pressers and all low expressers expanded into colonies (not shown). A single clone of 
several, containing intermediate levels of nuclear fluorescence, was further amplified 
in growth medium supplemented with 50 to 250 µg/ml Geneticin and was used for fur-
ther studies.  
Construction of recombinant baculoviruses. Full-length US3 and US3(K220A) 
were PCR amplified from viral DNA of HSV-1(F) or the US3 mutant virus vRR1204, 
respectively. The PCRs used primers with a BglII restriction endonuclease site incor-
porated into the forward primer (5'-TAA TAG ATC TAT GGC CTG TCG TAA GTT 
TTG-3') and an EcoRI site in the reverse primer (5'-ATA TGA ATT CTC ATT TCT 
GTT GAA ACA GCG-3'; restriction sites are in italics). PCR products were then 
cloned into the BamHI and EcoRI sites of the pGEX4T-1 vector such that they were in 
frame with the gene encoding glutathione-S-transferase (GST). DNA in the plasmid 
clones was sequenced, and those clones with the proper GST-US3 fusions were used as 
templates for a second PCR to amplify GST-US3 and GST-US3(K220A). This second 
PCR used primer 5'-AGG CAG ATC TAT TCA TGT CCC CTA TAC TAG-3' contain-
ing another BglII site (italicized) and the US3 reverse primer. Amplicons were then 
subcloned into the BglII/EcoRI sites of the pBacPAK8 vector (Clontech). This con-
struct was then transfected into insect Sf9 cells along with BacPAK6 baculoviral DNA 
(Clontech) according to the instructions of the BacPAK baculovirus expression system, 
and recombinant baculoviruses expressing the target proteins were plaque purified and 
amplified to produce viral stocks.  
Antibodies and immunofluorescence. Polyclonal chicken antibody against 
pUL34 was a kind gift from R. J. Roller (163). Chicken anti-lamin A/C polyclonal and 
rabbit anti-pUL31 antisera were prepared in our laboratory and were described previ-
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 ously (168, 169). Lamin B-specific goat polyclonal antibody was purchased from 
Santa Cruz Biotechnology (catalog number sc-6218).  
To characterize the localization of pUL31 and lamin A/C in infected cells, 200 µl 
of rabbit anti-pUL31 antisera was adsorbed against an acetone powder (177) prepared 
from approximately 2 x 108 Hep2 cells that were infected 24 h previously with a UL31 
deletion virus (107). The powder and antisera were added to 4 ml phosphate-buffered 
saline (PBS) containing 1% bovine serum albumin (BSA) and were mixed overnight. 
After centrifugation, the supernatant was passed through a 0.2-µm-pore-sized filter.  
Hep2 cells growing on glass coverslips were mock infected or infected with wild-
type HSV-1(F), US3 null, or US3(K220A) HSV-1 at a multiplicity of infection (MOI) 
of 5.0 for 16 h. Cells were fixed with 3% paraformaldehyde for 15 min, followed by 
treatment for 5 min at –20°C in methanol. The cells were then permeabilized with 
0.1% Triton X-100 and reacted with 10% human serum in PBS to block nonspecific 
immunoreactivity and were subsequently probed with the preadsorbed pUL31 rabbit 
polyclonal antibody diluted 1:50 in PBS supplemented with 1% BSA. Ten percent 
BlockHen II (Aves Lab) was used for a second round of blocking before probing with 
a 1:200 dilution of chicken anti-lamin A/C polyclonal antibody. Bound primary anti-
bodies were recognized by Texas Red-conjugated donkey anti-rabbit and fluorescein 
isothiocyanate (FITC)-conjugated donkey anti-chicken immunoglobulin (Jackson Im-
munoResearch).  
In some experiments, the cell line expressing eGFP-lamin A/C was mock infected 
or infected as described above, fixed in 3% paraformaldehyde, and permeabilized with 
0.1% Triton X-100. Epitopes were then blocked by incubation with 10% human serum 
in PBS for 1 h, followed by blocking with 10% BlockHen II and reaction with pUL34-
specific antisera diluted 1:200. After extensive washing, primary antibody was recog-
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 nized by Texas Red-conjugated donkey anti-chicken immunoglobulin (Jackson Immu-
noResearch).  
Images were visualized and recorded using either an Olympus or a Zeiss laser 
scanning confocal microscope equipped with a 488-nm argon or 568-nm krypton laser, 
respectively, and associated software. Digital images were exported in a tagged image 
file format (TIFF) to Adobe Photoshop for processing.  
Purification of wild-type and mutant HSV-1 pUS3. Sf9 cells were infected 
with recombinant baculoviruses expressing GST-pUS3 or GST-pUS3(K220A) and 
were lysed 42 hr post infection by brief sonication in ice-cold lysis buffer (50 mM Tris 
[pH 7.5], 100 mM NaCl, 5 mM MgCl2, 0.1% NP-40, 10% glycerol) containing 1x 
Complete protease inhibitor cocktail (Roche). The US3 proteins were purified from the 
lysates by affinity chromatography using glutathione Sepharose beads (Amersham) as 
previously described (89). Proteins were eluted in 100 mM reduced glutathione ac-
cording to the manufacturer's protocol and dialyzed into storage buffer (20 mM Tris-
HCl [pH 7.5], 25 mM KCl, 0.1 mM EDTA, 2 mM dithiothreitol [DTT], 50% glyc-
erol). Protein concentration was determined by an RC DC protein assay kit (Bio-Rad), 
and aliquots were frozen at –80°C.  
GST fusion proteins were partially purified from Escherichia coli lysates, as de-
scribed previously (162), and retained on the Sepharose beads without elution for reac-
tions. Protein concentration was estimated by elution and separation by sodium dode-
cyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed by comparison 
with known amounts of BSA standards stained with Coomassie brilliant blue.  
In vitro kinase assay. A kinase assay was performed using purified GST-pUS3 or 
GST-pUS3(K220A) essentially as described previously, with minor modifications (21). 
Briefly, 0.1 µg GST-pUS3 or at least an equivalent amount of GST-pUS3(K220A) was 
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 incubated separately with 1 to 3 µg of partially purified E. coli-expressed GST fusion 
proteins for 30 min at 30°C in 50 µl US3-specific kinase buffer (50 mM Tris [pH 9.0], 
20 mM MgCl2, 0.1% NP-40, 1 mM DTT) containing 10 µM ATP, and 10 µCi [γ-
32P]ATP (Amersham). The Sepharose beads bearing the fusion proteins were then 
washed three times with TNE buffer (20 mM Tris-HCl [pH 8.0], 100 mM NaCl, 1 mM 
EDTA) and in some cases were resuspended in bacteriophage lambda pyrophosphatase 
(λ-PPase) buffer containing 200 U of enzyme (New England Biolabs) and incubated 
for another 30 min at 30°C. The proteins on the beads were again washed three times 
in TNE. All the samples were dissolved in SDS-PAGE sample buffer (10 mM Tris-
HCl [pH 8.0], 10 mM ß-mercaptoethanol, 20% glycerol, 5% SDS, trace amounts of 
bromophenol blue) and subjected to electrophoresis in a 12% polyacrylamide gel in the 
presence of 0.1% SDS. Gels were then stained with Coomassie brilliant blue, dried, 
and autoradiographed using X-ray film (Pierce).  
Lamin disassembly assay. A previously described lamin disassembly assay was 
modified for the current studies (28). Approximately 1 x 107 Hep2 cells were homoge-
nized in 5.0 ml nuclear buffer (250 mM sucrose, 5 mM MgCl2, 25 mM KCl, 10 mM 
Tris [pH 7.4], 1 mM DTT, 1x Complete protease inhibitor cocktail [Roche]) by three 
strokes of a Dounce homogenizer. Nuclei were pelleted at 800 x g for 10 min in a re-
frigerated tabletop centrifuge (Eppendorf). The supernatant was discarded, and pel-
leted nuclei were resuspended in nuclear buffer and then permeabilized by the addition 
of 0.1% Triton X-100, followed by incubation on ice for 20 min. Nuclei were again 
pelleted at 800 x g for 10 min, and the supernatant was removed. The pelleted perme-
abilized nuclei were then washed twice with an excess volume of US3-specific kinase 
buffer and finally resuspended in 400 µl of this buffer.  
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 For the in vitro disassembly assay, three 80-µl aliquots of resuspended nuclei 
were incubated with 1 µg GST-pUS3 or GST-pUS3(K220A) in 120 µl kinase buffer in 
the presence or absence of 1 mM ATP. After 30 min of incubation at 30°C, the reac-
tion mixture tubes were gently vortexed, and 10 µl of the reaction mixtures (samples 
designated L) were set aside. All subsequent steps were performed at 0 to 4°C. After 
centrifugation at 2,000 x g for 5 min, supernatants of each sample (30 µl) were col-
lected and were designated S1. The remaining nuclei were centrifuged again at 10,000 
x g for 2 min, and equal volumes of the supernatants were collected and designated S2. 
Proteins in the L, S1, and S2, samples were denatured in SDS-PAGE sample buffer, 
electrophoretically separated in denaturing polyacrylamide gels, and transferred to ni-
trocellulose for immunoblotting with lamin-specific antibodies.  
Two-dimensional gel electrophoresis. To solubilize lamins, 2 x 106 infected 
Hep2 cells were lysed directly on culture dishes into 250 µl of urea rehydration buffer 
{9 M urea, 4% CHAPS [3-[(3-cholamidopropyl)-dimethylammonio]-1-
propanesulfonate], 50 mM DTT, 0.2% ampholytes [Bio-Rad]} containing 1x Com-
plete protease inhibitor cocktail (Roche) and a serine/threonine phosphatase inhibitor 
(10 mM NaF) (99). Approximately 100 µg of protein was subjected to isoelectric fo-
cusing in a Bio-Rad Protean isoelectric focusing cell using an 11-cm-long pH 3.0 to 
10.0 nonlinear or a pH 5.0 to 8.0 linear immobilized pH gradient ReadyStrip (Bio-
Rad). For separation in the second dimension, the strips were loaded on precast Crite-
rion 10% bis-Tris polyacrylamide gels (Bio-Rad), followed by electrophoresis. The 
separated proteins were then transferred electrically to nitrocellulose for immunoblot-
ting.  
In some experiments, cells were first permeabilized in 0.5% CHAPS on ice for 5 
min in the presence of Complete protease inhibitor, clarified by centrifugation at 800 x 
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 g for 5 min at 4°C, and incubated with 400 U of λ-PPase in a supplied buffer (New 
England Biolabs) at 30°C for 30 min. After this reaction, cells were repelleted and 
lysed in urea rehydration buffer, followed by two-dimensional electrophoresis and 
immunoblotting.  
Immunoblotting. Nitrocellulose sheets bearing proteins of interest were blocked 
in 5% nonfat milk plus 0.2% Tween 20 for at least 2 h. Membranes were then probed 
with lamin A/C chicken polyclonal antibody and lamin B goat polyclonal antibody if 
needed. Primary antibodies were detected by horseradish peroxidase-conjugated rabbit 
anti-chicken (Jackson ImmunoResearch) and/or bovine anti-goat secondary antibodies 
(Santa Cruz Biotechnology). Bound immunoglobulin was visualized by enhanced 
chemiluminescence (Pierce) followed by exposure to X-ray film. Signal intensities 
were quantified and calibrated using a Syngene Chemi-Genius imaging system and 
associated GeneTools software as needed. 
Results 
US3 kinase activity modifies nuclear lamin A/C organization and localization 
of pUL31 and pUL34 during HSV-1 infection. Because Hep2 cells are generally re-
sistant to HSV-induced cytoskeletal changes, one goal of these studies was to investi-
gate whether the nuclear lamina of Hep2 cells was affected by US3, as was previously 
reported with Vero cells (15). In considering the design of such experiments, we noted 
in previous studies that some commercial lamin A/C antibodies are rendered less im-
munoreactive upon infection with HSV-1 (162). To avoid the potentially misleading 
effects of antibody staining, we attempted to use eGFP-lamin A/C in transient-
expression assays but found that overexpression of such constructs disrupted the nu-
clear lamina in many cells, even in the absence of infection (not shown). To avoid 
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 these overexpression artifacts, and under the expectation that cells experiencing asso-
ciated cytotoxic effects should be outgrown by healthy cells expressing the construct, 
we sought to produce a cell line stably expressing eGFP-lamin A/C. Hep2 cells were 
therefore transfected with a plasmid conferring G418 resistance and encoding eGFP 
fused to lamin A/C. Individual cells expressing eGFP were cloned by FACS, followed 
by amplification in G418-containing medium. Cell lines expressing fluorescence in 
association with the nuclear rim were selected for further study.  
One such cell line was either mock infected or infected with wild-type HSV-1(F) 
or virus vRR1204 bearing a mutation inactivating US3 kinase activity [designated 
US3(K220A) in Fig. 2.1] (174). At 16 h postinfection, cells were fixed, permeabilized, 
and reacted with chicken antibody directed against UL34 protein. Bound chicken anti-
body was revealed by reaction with Texas Red-conjugated donkey anti-chicken anti-
body, followed by confocal microscopy. 
In general, the shape of nuclei infected with HSV-1(F) was more irregular than 
that of uninfected cells. As revealed upon collection of confocal images at high magni-
fication, followed by digital enlargement, eGFP-lamin A/C appeared mostly as a series 
of filaments and dots linking larger solid areas of fluorescence. Overall, the fluores-
cence appeared in a reticular pattern in the nuclear rim of both the mock-infected and 
the HSV-1(F)-infected cells. The reticular pattern was most readily noticeable in opti-
cal sections of the tops and bottoms of the cells in which a planar view of the nuclear 
lamina was most readily apparent (Fig. 2.1B). In both mock-infected and HSV-1(F)-
infected cells, the reticular filaments were bordered by spaces that lacked eGFP fluo-
rescence. Although the reticular pattern of NM fluorescence in mock-infected and 
HSV-1-infected cells did not differ significantly, most cells infected with HSV-1(F) 
contained larger regions near the bottom of the cell that were devoid of fluorescence 
(Fig. 2.1B, arrow). In general, the appearance of these cells is in contrast to the
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Figure 2.1 Confocal analyses of a Hep2-derived cell line stably expressing 
eGFP-lamin A/C. Cells were either mock infected (Mock) or infected with 5.0 
PFU/cell of wild-type HSV-1(F) (designated F) or mutant US3(K220A), lacking 
pUS3 kinase activity. Cells were fixed and permeabilized at 16 h postinfection 
and stained with polyclonal anti-pUL34 chicken polyclonal antibody, followed 
by Texas Red-conjugated secondary antibody, and examined with confocal mi-
croscopy. (A) Analysis of optical sections taken through the middle of cells. (B) 
Optical sections taken at the bottom of cells. Regions indicated in white rectan-
gles in panels D, E, F, J, K, and L are digitally magnified in the panel immedi-
ately below them (panels G, H, I, L, M and N, respectively). Coincident signals 
in the merged images (rightmost column) are indicated by a yellow color. An 
arrow indicates one region of the infected cell containing less lamin A/C than 
surrounding areas. 
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Figure 2.1 (Continued) 
 
 appearance reported for HSV-infected Hep2 cells expressing eGFP-lamin A/C tran-
siently in which large discrete holes in the eGFP-specific fluorescence were seen 
(186). Differences in the two studies include the use of transient expression of eGFP-
lamin A/C, followed by infection with 50 PFU/cell in the previous study, versus the 
use of a stably expressing cell line and an MOI of 5 in the current study.  
In contrast to the results obtained upon infection with wild-type virus, the pattern 
of eGFP-lamin A/C fluorescence was markedly different after infection with the 
kinase-inactivated US3 mutant virus. Specifically, sites within the reticular pattern 
lacking eGFP fluorescence were substantially larger in diameter and more likely oval 
to round. In addition, the larger regions of HSV-1(F)-infected cells lacking the most 
eGFP in the nuclear rim displaying a paucity of lamin A/C were absent. These results 
indicated that the kinase activity of pUS3 is necessary for the distribution of lamin A/C 
normally seen in cells infected with wild-type HSV.  
As noted previously, pUL34-specific immunostaining was distributed throughout 
the nuclear rim in Hep2 cells infected with the wild-type virus HSV-1(F) (163). This 
was readily apparent in optical cross-sections taken through the middle of cells (Fig. 
2.1A). Superficially, eGFP-lamin A/C fluorescence and pUL34-specific immunostain-
ing mostly colocalized in these cross-sections. However, high magnification of planar 
sections near the bottom of the cells revealed regions containing only pUL34 immu-
nostaining or only eGFP-lamin A/C, as well as regions where eGFP-lamin A/C and 
pUL34 colocalized (Fig. 2.1B). In the larger regions lacking lamin A/C, seen only in 
cells infected with HSV-1(F), pUL34 immunostaining could also be detected.  
In striking contrast to the localization of pUL34 in HSV-1(F)-infected cells, cells 
infected with the US3 kinase mutant contained pUL34 almost exclusively within punc-
tate foci at the nuclear rim in optical cross-sections taken near the centers of cells (Fig. 
2.1A) (13, 170, 176). These regions invariably corresponded to the well-defined 
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 breaches in the reticular distribution of eGPF-lamin A/C noted above. This dramatic 
change in the distribution of lamin A/C became even more striking in optical sections 
that focused on the bottom of infected cell nuclei. In such sections (Fig. 2.1B, lower 
two rows), foci staining intensely with pUL34-specific antibody coincided with regions 
that entirely lacked detectable eGPF-lamin A/C. We conclude that the kinase activity 
of pUS3 is necessary for partial colocalization of pUL34 and eGFP-lamin A/C at the 
nuclear rim and for the wide distribution of pUL34 throughout the nuclear rim. These 
data are consistent with previous immunostaining studies indicating that US3 kinase 
activity is necessary for the normal distribution of pUL34 with Vero cells (13, 170, 
176).  
To ensure that the above-described observations were not idiosyncratic to the 
eGFP-lamin A/C cell line, Hep2 cells were also mock infected or were infected with 
the wild-type HSV-1(F), the US3 kinase-dead viral mutant, or a viral mutant contain-
ing a deletion of US3. The cells were fixed at 16 h after infection and were immu-
nostained with antibody against pUL31 and a chicken polyclonal antibody directed 
against lamin A/C that was insensitive to HSV-induced epitope masking (162).  
As shown in Fig. 2.2, lamin A/C localized in a reticular pattern in mock-infected 
cells that superficially resembled that of cells infected with HSV-1(F), except that 
some regions near the nuclear rim of infected cells did not stain with lamin A/C anti-
body (e.g., as shown by the arrow in Fig. 2.2D). pUL31 immunostaining also appeared 
in a reticular pattern, but this pattern did not completely overlap that of lamin A/C 
immunostaining. Specifically, regions containing only pUL31 immunostaining or only 
lamin A/C immunostaining and colocalization of these were observed. Thus, the pat-
terns of pUL31 immunostaining were similar to those of pUL34, as indicated above. 
More importantly for the purposes of subsequent experiments herein, planar sec-
tions of cells infected with either the US3 deletion virus or the kinase-dead mutant
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Figure 2.2 Digital confocal images of Hep2 cells immunostained with anti-
bodies to lamin A/C and pUL31. Hep2 cells were mock infected (Mock) or in-
fected with a US3 deletion mutant (dUS3), a mutant lacking US3 kinase activity 
[US3 (K220A)], or wild-type virus HSV-1(F) (designated F). Sixteen hours after 
infection, the cells were fixed, permeabilized, and reacted with preadsorbed rab-
bit polyclonal antiserum against pUL31 or chicken immunoglobulin Y directed 
against lamin A/C. Bound antibodies were revealed with Texas Red-conjugated 
anti-rabbit antibody or FITC-conjugated anti-chicken antibodies. Optical sec-
tions closest to the glass coverslips are shown. An arrow indicates regions of the 
nuclear rim that are mostly devoid of lamin A/C immunostaining. White boxes 
indicate areas of interest that are magnified in an inset in the same panel. 
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 virus revealed well-circumscribed, roughly circular regions that completely lacked 
lamin A/C immunostaining. These regions invariable contained most of the pUL31 
immunostaining in the cell, i.e., there were very few regions in which pUL31 and lamin 
A/C colocalized except on the edges of these "holes" in the nuclear lamina. Taken to-
gether, the results are reminiscent of the above-described study using the eGFP-lamin 
A/C-expressing cell line and indicate that US3 kinase and its activity are required for 
(i) partial colocalization of pUL31/pUL34 with lamin A/C, (ii) for the reticular distribu-
tion of lamin A/C and pUL31/pUL34 seen in cells infected with wild-type viruses, and 
(iii) for the large regions devoid of lamin A/C immunostaining as seen in cells infected 
with HSV-1(F).  
Adaptation of a US3 in vitro kinase assay and identification of lamin A as a 
substrate. The above-described observations indicated that the kinase activity encoded 
by the US3 gene altered lamin A/C distribution. The simplest mechanism to explain 
this phenomenon would be that US3 phosphorylates lamin A/C directly, thereby alter-
ing lamin A/C's interaction with other proteins in the nuclear lamina. Further studies 
were undertaken to test this possibility.  
Inasmuch as preliminary observations indicated that the Thr-10 residue of lamin 
A/C (within the sequence Arg7-Arg8-Ala9-Thr10-Arg11-Ser12, from GenBank accession 
number NP_733821) matched the optimal consensus target, experiments were de-
signed to determine whether lamin A/C could be phosphorylated by the US3 kinase. 
Thus, US3 fused to GST was expressed in insect SF9 cells and was purified on glu-
tathione beads as previously described (89). As a control, the kinase-inactivated mu-
tant US3(K220A) was purified in the same manner. Coomassie blue staining of the 
proteins indicated at least 90% purity (Fig. 2.3A).  
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Figure 2.3 Analysis of in vitro kinase activities of purified GST-pUS3 and the 
mutant GST-pUS3(K220A). (A) Denaturing polyacrylamide gel containing pu-
rified GST-pUS3 and GST-pUS3(K220A) and stained with Coomassie brilliant 
blue. (B) In vitro kinase reaction. The fusion proteins indicated at the top of the 
left panel were mixed with 100 ng GST-pUS3. After 30 min at 30°C in the pres-
ence of [γ-32P]ATP, the reaction mixtures were resolved on a denaturing poly-
acrylamide gel and visualized by Coomassie (CBB) staining (left panel) and 
autoradiography (right panel). The position of the approximately 90,000 appar-
ent Mr GST-pUS3 fusion protein is shown in the right panel. GST-pUL34 (amino 
acids 205 to 275) is a negative control inasmuch as it does not contain the phos-
phorylation consensus site in pUL34. (C) In vitro kinase activities of GST-pUS3 
and GST-pUS3(K220A). Purified GST-pUS3 (0.1 µg) or 0.5 µg GST-
pUS3(K220A) was incubated with [γ-32P]ATP in the presence or absence of par-
tially purified GST-pUL31 as a potential substrate, followed by subsequent incu-
bation in the presence or absence of λ-PPase. The reaction components were de-
natured, electrophoretically separated, and stained with Coomassie brilliant blue 
(CBB, bottom panel) or dried and autoradiographed (upper panel). For compara-
tive purposes, the molecular weight standards from the bottom panel were cop-
ied and aligned with the top panel, using Adobe Photoshop. Sizes of the stan-
dards are indicated to the left of the figure in thousands [K]). 
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 To test their enzymatic activities, 0.1 µg of the purified proteins was reacted with 
purified GST, or with pUL31 fused to GST, in the presence of [γ-32P]ATP. As an addi-
tional negative control, the pUL34 amino acids 205 to 275 region, comprising a region 
of pUL34 separate from that of the known US3 phosphorylation site, was also subjected 
to the kinase assay. The reaction mixtures were then electrophoretically separated on a 
denaturing polyacrylamide gel and subjected to autoradiography (Fig. 2.3B and C). 
Consistent with a previous report (89), GST-pUS3 phosphorylated itself (Fig. 2.3B and 
C, lanes 2 and 5), whereas GST-pUS3(K220A) had no such activity (Fig. 2.3C, lane 4). 
GST-pUS3 also readily phosphorylated the partially purified pUL31-GST fusion pro-
tein (Fig. 2.3C, lane 5). In contrast, GST-pUS3 did not phosphorylate GST: GST fused 
to the UL34 amino acids 205 to 275 or other E. coli proteins within the GST-pUL31 
preparation that were readily visible on the Coomassie blue-stained gel (Fig. 2.3B and 
C, lane 5). GST-pUS3(K220A) did not phosphorylate GST-pUL31 or other proteins in 
the E. coli lysate (Fig. 2.3C, lane 7). As expected, addition of bacteriophage λ-PPase 
significantly reduced the phosphorylation of GST-pUS3 (Fig. 2.3C, lane 3) and elimi-
nated the phosphorylation of GST-pUL31 that was mediated by GST-pUS3 (Fig. 2.3C, 
lane 6).  
Collectively, these data indicate that the US3 gene-encoded kinase activity was 
functional and specific inasmuch as it induced phosphorylation of two known sub-
strates (pUL31 and pUS3) but not GST or other tested proteins. In addition, the data 
indicate that the K220A mutation inactivated all detectable US3 kinase activity. Thus, 
an efficient and specific in vitro kinase assay system was established for testing of ad-
ditional substrates.  
To determine whether lamin A was a target of the US3 kinase, GST fused to 
lamin A was purified from E. coli and subjected to the in vitro kinase assay. The re-
sults, shown in Fig. 2.4, indicated that the lamin A-GST fusion protein was heavily
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Figure 2.4 Phosphorylation of lamin A by US3 kinase in vitro. Full-length 
lamin A fused to GST was partially purified and reacted with either purified 
GST-pUS3 or GST-pUS3(K220A) in the presence of [γ-32P]ATP, followed by 
incubation in the presence or absence of λ-PPase. The reaction components were 
separated on a polyacrylamide gel and stained with Coomassie brilliant blue 
(CBB, lower panel) and autoradiographed (upper panel). 
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 phosphorylated in the presence of GST-pUS3 (Fig. 2.4, lane 1) but not in the presence 
of GST-pUS3(K220A) (Fig. 2.4, lane 3). The phosphorylation of lamin A-GST wa-
seliminated upon incubation with λ-PPase (Fig. 2.4, lane 2). These data indicate that 
lamin A is an in vitro substrate of the US3 kinase. 
US3 has broader kinase activity than predicted and phosphorylates lamin 
A/C at multiple sites in vitro. Because lamin A/C is phosphorylated at different sites 
depending on the physiological mechanism of lamin disassembly (see the introduc-
tion), it was of interest to identify which region of lamin A was phosphorylated by the 
US3 kinase. To identify the region targeted by the US3 kinase, five subfragments of 
lamin A fused to GST were purified from lysates of E. coli and incubated with GST-
pUS3 in the presence of [γ-32P]ATP, followed by denaturing gel electrophoresis, 
Coomassie blue staining, and autoradiography. The amount of radioactive phosphate 
in a given protein band was normalized to the amount of protein present in the reaction 
mixtures and expressed as a percentage of the degree to which full-length lamin A was 
phosphorylated. The results are shown in Fig. 2.5. 
Comparing the radiolabeling of full-length protein with that of truncated lamin A 
proteins normalized to the amount of protein in individual reaction mixtures revealed 
that full-length lamin A was phosphorylated to a higher degree than any single sub-
fragment. While only Thr-10 matched the optimal US3 kinase consensus sequence, it 
was surprising to find that all five subfragments of lamin A were phosphorylated to 
various extents when reacted with purified GST-pUS3. Although the head (Fig. 2.5, 
lane H) domain (amino acids 1 to 129) containing the US3 consensus site was phos-
phorylated to a level that was 14% of that of full-length lamin A/C, the tail 1 (Fig. 2.5, 
lane T1) domain (amino acids 369 to 519) was even more heavily phosphorylated (to 
37% of that of full-length lamin A/C), despite the lack of a pUS3 phosphorylation
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Figure 2.5 (A) Schematic diagram of lamin A primary structure and five 
subdomains fused to GST. The amino acids (AA) in each peptide subdomain 
are indicated, assuming that the start methionine codon is 1 [reprinted from ref-
erence (162)]. (B) Full-length (FL) lamin A or lamin A fragments fused to 
GST and reacted with GST-pUS3 kinase. The five GST fusion proteins bear-
ing fragments of lamin A as detailed for panel A were purified, mixed with US3-
GST and [γ-32P]ATP, and electrophoretically separated and stained with 
Coomassie brilliant blue (lower panel) and autoradiographed (upper panel). H, 
head; R1, rod1; R2, rod2; T1, tail 1; T2, tail2; lane C, GST-pUL34 (amino acids 
205 to 275). 
 consensus motif. As expected from previous results, GST-pUL34 (amino acids 205 to 
275) lacking the US3 kinase consensus motif was not phosphorylated by pUS3 (Fig. 
2.5, lane C).  
Taken together, these observations indicate that the full-length lamin A-GST was 
phosphorylated at multiple sites within lamin A. It follows that, at least in vitro, the 
previously derived US3 kinase consensus site is overly restrictive and other sites can 
also be phosphorylated.  
US3 induces partial lamin A/C solubilization in purified Hep2 cell nuclei. Be-
cause the phosphorylation of lamins is well known to regulate lamin disassembly, it 
was of interest to determine whether phosphorylation by US3 kinase could increase the 
solubility of lamin A/C. This was of particular interest because the complex structure 
of the nuclear lamina might preclude the access of pUS3 to lamin A/C or lamin A/C 
phosphorylation sites. To test whether US3 kinase activity could modify the nuclear 
lamina, an in vitro lamina disassembly assay was developed.  
Briefly, nuclei from Hep2 cells were isolated, permeabilized, and incubated in 
US3 kinase buffer with GST-pUS3 or GST-pUS3(K220A) in the presence or absence of 
ATP. After the reaction, nuclei were pelleted by centrifugation, and equal amounts of 
supernatant were collected for analysis. To ensure minimal contamination of the su-
pernatants with insoluble material, nuclei were subjected to a second high-speed cen-
trifugation, and a portion of the supernatants were again collected. Protein in the su-
pernatants and pellets were denatured in SDS, electrophoretically separated, trans-
ferred to nitrocellulose, and probed with a chicken polyclonal antibody to lamin A/C.  
As shown in Fig. 2.6, the presence of GST-pUS3 and ATP increased the amount 
of lamin A/C solubilized into the supernatants by approximately twofold compared to 
that in reaction mixtures containing either GST-pUS3(K220A) plus ATP or GST-pUS3
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Figure 2.6 Immunoblot of total and solubilized lamin A/C from permeabi-
lized Hep2 cell nuclei reacted with wild-type and mutant US3-encoded 
kinases. Purified and permeabilized Hep2 cell nuclei were incubated for 30 min 
in the presence or absence of the indicated fusion proteins and ATP. As a load-
ing control, a sample of the total material (L) was collected immediately after the 
reactions. S1 was collected after centrifugation at low speed. A second super-
natant fraction (S2) was collected after high-speed centrifugation. Proteins in the 
various fractions were denatured in SDS, electrophoretically separated, trans-
ferred to nitrocellulose, and probed with lamin A/C-specific antibody. Bound 
immunoglobulin was detected by a horseradish peroxidase-conjugated secondary 
antibody and chemiluminescence. The intensity of the chemiluminescence sig-
nals of the lamin A and C bands were quantified using a Syngene Chemi-Genius 
imaging system and associated GeneTools software, and the amount of 
chemiluminescence was pooled. The reported percentages represent the intensity 
of chemiluminescence in that lane relative to that detected in the first lane (sam-
ple L of GST-pUS3 plus ATP). 
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 without ATP. This reaction was repeated three times with similar results. We conclude 
that US3 kinase activity and ATP are sufficient to increase the solubility of lamin A/C 
from an endogenous preexisting nuclear lamina in vitro. 
Lamin A/C is phosphorylated in HSV-infected cells, and the full spectrum of 
phosphorylation requires pUS3 kinase activity. The studies described above were 
performed in vitro. In order to determine whether US3 phosphorylates lamin A/C in 
infected cells, two-dimensional electrophoretic analysis of lamin A/C was performed 
under various conditions. Specifically, Hep2 cells were mock infected or infected with 
5.0 PFU/cell of wild-type HSV-1(F) or the US3(K220A) mutant virus and were lysed 
16 h postinfection in 9 M urea to solubilize nuclear lamins (99). The proteins were 
separated by isoelectric focusing in the first dimension and by size in the second di-
mension. The electrophoretically separated proteins were transferred to nitrocellulose, 
and the positions of various isoforms of lamin A/C were revealed by immunoblotting 
with lamin A/C-specific chicken polyclonal antibody. The immunoblots were also 
probed with a goat antibody directed against lamin B1 and B2 with predicted isoelec-
tric points of 5.11 and 5.29, respectively.  
The results (Fig. 2.7) showed that unlike lamin A/C, neither lamin B isoform 
showed consistent or obvious shifts in isoelectric points under the various conditions 
tested. The lamin B-specific spots were therefore used as an internal control for align-
ment of the lamin A/C immunoblots. Upon separation in the first dimension in the pH 
3.0 to 10.0 range, lamin A/C from mock-infected cells and cells infected with wild-
type HSV-1(F) were broadly distributed throughout a wide pH range. Superficially, 
the patterns of lamin A/C-specific spots were similar in distribution, but mock-infected 
cells contained lamin A/C isoforms that were evenly distributed throughout the middle 
of the range, whereas some individual spots were more defined and easier to discern in  
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Figure 2.7 Two-dimensional gel electrophoresis and immunoblots of lamin 
A/C isoforms from mock-infected and HSV-infected cells. Hep2 cells were 
mock infected or infected with wild-type HSV-1(F) (panels labeled F) or mutant 
US3(K220A). Proteins were extracted in buffer containing 9 M urea to solubilize 
lamins and separated by isoelectric focusing in the first dimension using nonlin-
ear pH gradients from pH 3.0 to 10.0 (A and B) or linear pH gradients 5.0 to 8.0 
(C) and by size on denaturing polyacrylamide gels in the second dimension. The 
proteins were then transferred to nitrocellulose and probed with polyclonal 
chicken antibody directed against lamin A/C or a rabbit antibody against lamin 
B1 and lamin B2. Bound immunoglobulin was detected by appropriate horserad-
ish peroxidase-conjugated secondary antibodies. Chemiluminescence generated 
by the addition of appropriate substrates was recorded on X-ray film. In some 
experiments (λ-PPase), proteins were reacted with λ-PPase before electropho-
retic separation. For comparative purposes, the three blots in panels A and B 
were aligned by position of lamin B-specific spots and by distance from the cati-
onic and anionic poles. The positions of the terminal poles on the pH strip of the 
four immunoblots shown in panel C are also aligned. For orientation, the posi-
tions of the lamin A-, B-, and C-specific spots are indicated to the left of the top 
immunoblot shown in panels A and C. 
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 lamin A/C taken from cells infected with HSV-1(F). This suggested that lamin A/C in 
HSV-1(F)-infected cells are modified differently than in mock-infected cells, but these 
differences are subtle, at least as viewed by two-dimensional gel electrophoresis. In 
contrast, however, US3(K220A)-infected cells lacked many of the more acidic lamin 
A/C species present within the populations of lamin A/C isoforms in HSV-1(F)-
infected or mock-infected cells. The predicted isoelectric points of lamin A and C are 
6.57 or 6.40, respectively. Separation in the first dimension using a narrower pH range, 
closer to the lamin A/C isoelectric point (pH 5.0 to 8.0) (Fig. 2.7C), confirmed that 
numerous acidic lamin A/C species detected in HSV-1(F)-infected cells were absent 
from cells infected with the US3 kinase mutant. 
Because the wide range of distribution of lamin A/C on first dimension might be 
due to posttranslational modifications other than phosphorylation (such as polyade-
nylylation), samples were treated with λ-PPase, followed by two-dimensional electro-
phoretic separation and immunoblotting with lamin A/C antibody. As shown in Fig. 
2.7B and C, phosphatase treatment of lamins from mock-infected cells resulted in a 
dramatic loss of the most acidic species of lamin A/C, indicating that the acidity of 
these species is a consequence of phosphorylation. Moreover, λ-PPase treatment of 
lamin A/C also eliminated some acidic species detected in cells infected with the 
US3(K220A) mutant virus. Thus, US3 kinase activity cannot account for all of the 
lamin A/C phosphorylation in HSV-infected cells.  
Taken together, these data indicate that many of the acidic lamin A/C isoforms 
are phosphorylated species whose acidity in infected cells depends on US3 kinase ac-
tivity. We conclude that endogenous lamin A/C is phosphorylated during HSV-1 in-
fection and that the full spectrum of phosphorylation requires US3 kinase activity. 
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 Discussion 
The effect of US3 on the distribution of lamin A/C in HSV-1-infected cells. 
Using two different methods, we have shown that US3 kinase activity is necessary for 
the pattern of lamin A/C distribution in HSV-1-infected Hep2 cells. Whereas lamin 
A/C and pUL31 and pUL34 immunostaining partially colocalized in a reticular pattern 
in Hep2 cells infected with wild-type virus, the lack of kinase activity in infected cells 
caused pUL31 and pUL34 to localize solely within circular regions lacking lamin A/C. 
These regions were wider in diameter and more circumscribed than most areas of cells 
infected with wild-type viruses containing pUL31/pUL34 but lacking lamin A/C. Simi-
lar conclusions were reached in studies of Vero cells, with the exception that the dis-
ruption of the lamina induced by both wild-type and US3(–) viruses was considerably 
more dramatic than that of uninfected cells, probably as a result of using different cell 
lines in the two studies (146). Our results are not a consequence of epitope masking 
because we used an eGFP-lamin A/C-expressing cell line and a polyclonal antibody 
insensitive to this HSV-induced effect with similar results.  
We also noted subtle differences in the distribution of lamin A/C between the 
lamina of uninfected and HSV-1(F)-infected Hep2 cells. In both cases, the lamina con-
tained small regions that lacked eGFP-lamin A/C. In infected cells, many, but not all, 
of these contained pUL34 and pUL31, proteins that are incorporated into nascent viri-
ons and are required for envelopment of nucleocapsids (169, 170, 175). Unlike the re-
gions in uninfected Hep2 cells, larger regions of the nuclear rim, as viewed in planar 
sections, seemed to be devoid of lamin A/C in infected cells. It is unclear if these re-
gions also lack lamin B or correspond to regions that communicate with the HSV 
DNA replication compartment (185). In any event, the concentration of pUL31 and 
pUL34 in both of the larger regions lacking lamin A/C and small gaps in the reticular 
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 pattern of lamin A/C argue that they both represent potential sites of virion egress. In 
contrast, the absence of US3 kinase or its activity restricted potential envelopment sites 
to fewer, very discrete, and round foci that also lacked lamin A/C.  
These data suggest that during infection with wild-type virus, some potential en-
velopment sites (i.e., in the reticular pattern) may be very small or a consequence of 
localized thinning of the lamina, whereas others, while larger, remain somewhat dif-
fuse. These observations suggest a sophisticated manipulation of the dynamics of nu-
clear lamins by HSV to promote virus egress while maintaining most laminar struc-
ture. This balance depends on US3 kinase activity, inasmuch as the absence of this ac-
tivity causes very discrete breaches in the lamina as viewed by the distribution of 
eGFP-lamin A/C. It seems likely that capsids pass through these exaggerated breaches 
in the lamina and accumulate in the perinuclear space adjacent to these sites. This is 
supported by the observation that in the absence of US3, perinuclear virions accumu-
late in evaginations of the NM (170, 176). It would be useful to confirm this by live 
cell microscopy.  
How does US3 kinase activity preclude the presence of discrete "holes" in the nu-
clear lamina and aggregation of virions in the perinuclear space? We speculate that 
there are three possibilities. The first possibility is that US3 kinase activity serves to 
increase lamin turnover and dynamics. Thus, phosphorylation by US3 would remove 
lamin A/C from some regions where US3 accumulates. Subsequent dephosphorylation 
of these lamins (not accounted for in these studies) would allow their reincorporation 
into gaps in the lamina, similar to mechanisms by which the lamina expands during 
interphase (145). The result is a more dynamic and flexible lamina to facilitate nuclear 
egress at multiple sites and the absence of most obvious gaps, since these are subse-
quently filled in. A second, related possibility is that US3's effects on lamin A/C distri-
bution are unrelated to the direct phosphorylation of lamin A/C by US3. In this sce-
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 nario, US3 kinase would phosphorylate other proteins that would then serve to increase 
lamin A/C phosphorylation in infected cells, leading to fewer discrete breaches in the 
lamina. A third possibility is related to the effect of US3 kinase on the localization of 
pUL31 and pUL34. At least pUL31 likely encodes its own depolymerizing effects on 
the lamina (168, 190), and its concentration in discrete areas of the nuclear rim in the 
absence of US3 kinase activity might promote highly localized lamina disruption. The 
converse of this hypothesis is that US3's kinase activity serves to redistribute the lam-
ina depolymerizing, envelopment machinery (specifically the pUL34/pUL31 complex) 
more widely throughout the NM. Clearly, further studies are necessary to test specific 
aspects of these models and to determine whether US3's phosphorylation and dis-
placement of lamin A/C are related to the localization of pUL34/pUL31.  
Lamin A/C phosphorylation in infected cells. Two-dimensional gel electropho-
resis was chosen to characterize lamin A/C in infected and uninfected cells because of 
its ability to rapidly characterize differences between soluble and insoluble isoforms of 
lamin A/C. While it might seem surprising that the migration of lamin A/C in unin-
fected and HSV-1(F)-infected cells was only subtly different, we speculate that some 
of the phosphorylation of lamin A/C in mock-infected cells is consequential to phos-
phorylation by cellular kinases like cdc2 kinase in some mitotic cells (150, 151), 
whereas in HSV-infected cells, lamin A/C is primarily phosphorylated by the US3 
kinase (Fig. 2.7). Thus, while collectively the electrophoretic profiles under the two 
conditions are similar, the mechanisms responsible for lamin A/C phosphorylation in 
the two circumstances are very different. These interpretations are supported by the 
observations that (i) HSV-infected cells do not undergo mitosis late in infection (47), 
(ii) US3 can directly phosphorylate lamin A/C at multiple sites in vitro (Fig. 2.5), and 
(iii) most highly phosphorylated lamin A/C species in HSV-1(F)-infected cells are not 
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 detected upon infection with the US3 kinase mutant (Fig. 2.7). On the other hand, 
some phosphorylated species of lamin A/C were detected even in the absence of US3 
kinase activity, suggesting that other kinases also phosphorylate lamin A/C in HSV-
1(F)-infected cells.  
Substrates of the US3 kinase. It was surprising that multiple regions of lamin A 
could be phosphorylated by purified GST-pUS3, despite the fact that only codon 10 
matched the consensus sequence derived from previous analyses of peptide substrates 
(105, 158, 159). Indeed, some lamin A peptides lacking a bona fide pUS3 phosphoryla-
tion consensus sequence (e.g., amino acids 369 to 519 in the tail domain) were phos-
phorylated more heavily than the lamin A head domain bearing this motif (Fig. 2.5). In 
the same reactions, the US3 kinase did not phosphorylate a variety of E. coli proteins, 
nor GST, suggesting kinase specificity for lamin A/C. Parenthetically, the consensus 
phosphorylation site of cyclic AMP-dependent PKA phosphorylation is R-X-S/T or R-
R/K-X-S/T, i.e., very similar to and partially overlapping that of pUS3, although the Km 
values of the respective enzymes differ (155). Although it has been speculated that 
pUS3 kinase activity functionally overlaps that of PKA in HSV-infected cells (12), the 
spectrum of US3 kinase substrates is likely broader inasmuch as protein kinase A 
phosphorylates lamin A/C only at N-terminal amino acids 1 to 32 in vitro (48).  
These data indicate that the US3 kinase is more promiscuous than previously 
thought and suggest the existence of more substrates than previously predicted. Like 
other promiscuous kinases, it seems likely that the most important factor limiting 
phosphorylation by pUS3 would be access to the substrate in the living cell or virion, 
rather than the presence or absence of the previously reported phosphorylation motif. 
Given this consideration, it is reasonable to postulate that US3 kinase substrates other 
than lamin A/C could also contribute to alterations in the nuclear lamina of HSV-
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 infected cells. Candidates include lamin B, various lamin receptors, and the HSV-1 
UL31 protein. 
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 Abstract 
Previous results indicated that the UL34 protein (pUL34) of herpes simplex virus 1 
(HSV-1) is targeted to the nuclear membrane and is essential for nuclear egress of nu-
cleocapsids. The normal localization of pUL34 and virions requires the US3-encoded 
kinase that phosphorylates pUL34 and lamin A/C. Moreover, pUL34 was shown to in-
teract with lamin A in vitro. In the present study, glutathione S-transferase/pUL34 was 
shown to specifically pull down lamin A and lamin B1 from cellular lysates. To de-
termine the role of these interactions on viral infectivity and pUL34 targeting to the in-
ner nuclear membrane (INM), the localization of pUL34 was determined in Lmna–/– 
and Lmnb1–/– mouse embryonic fibroblasts (MEFs) by indirect immunofluorescence 
and immunogold electron microscopy in the presence or absence of US3 kinase activ-
ity. While pUL34 INM targeting was not affected by the absence of lamin B1 in MEFs 
infected with wild-type HSV as viewed by indirect immunofluorescence, it localized 
in densely staining scallop-shaped distortions of the nuclear membrane in lamin B1 
knockout cells infected with a US3 kinase-dead virus. Lamin B1 knockout cells were 
relatively less permissive for viral replication than wild-type MEFs, with viral titers 
decreased at least 10-fold. The absence of lamin A (i) caused clustering of pUL34 in 
the nuclear rim of cells infected with wild-type virus, (ii) produced extensions of the 
INM bearing pUL34 protein in cells infected with a US3 kinase-dead mutant, (iii) pre-
cluded accumulation of virions in the perinuclear space of cells infected with this mu-
tant, and (iv) partially restored replication of this virus. The latter observation suggests 
that lamin A normally impedes viral infectivity and that US3 kinase activity partially 
alleviates this impediment. On the other hand, lamin B1 is necessary for optimal viral 
replication, probably through its well-documented effects on many cellular pathways. 
Finally, neither lamin A nor B1 was absolutely required for targeting pUL34 to the 
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 INM, suggesting that this targeting is mediated by redundant functions or can be medi-
ated by other proteins. 
Introduction 
Herpesvirus nucleocapsids are assembled in the nucleus and become enveloped 
initially at the inner nuclear membrane (INM) in a reaction termed primary envelop-
ment (4). The herpes simplex virus UL31 and UL34 proteins (pUL31 and pUL34, re-
spectively) and their orthologs in other herpesviruses are targeted to the INM and are 
required for the primary envelopment reaction in many cell lines (70, 113, 169, 170, 
181). 
Upon infection of restrictive cells such as Vero and Hep2 with herpes simplex vi-
rus (HSV) deletion mutants lacking UL31 or UL34, nucleocapsids remain in the nu-
cleoplasm and infectious titers are reduced at least 1,000-fold (22, 110, 175).  
The UL34 protein is a type II integral membrane protein of 30,000 Mr, with a pre-
dicted 250-amino-acid (aa) nucleoplasmic domain, a 23-aa transmembrane domain, 
and 5 aa in the perinuclear space (121, 188). The UL31 protein is a largely hydropho-
bic phosphoprotein of 32,000 Mr that requires interaction with pUL34 for targeting to 
the nucleoplasmic face of the INM (121, 169, 230). While pUL31 and pUL34 are in-
corporated into nascent virions, they are undetectable in extracellular virions, suggest-
ing they are lost from the nascent virion when its envelope fuses with the outer nuclear 
membrane (62, 170). This observation is consistent with the most prominent model of 
virion egress in which the de-enveloped nucleocapsid subsequently gains a new enve-
lope by budding into cytoplasmic membranes (194). In the absence of the activity of a 
serine kinase encoded by alphaherpesvirus genes, such as HSV-1 US3, or upon dele-
tion of the HSV genes encoding glycoproteins B and H (gB and gH, respectively), 
virions accumulate aberrantly in the perinuclear space, suggesting that US3, gB, and 
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 gH promote the fusion of the nascent virion envelope with the outer nuclear membrane 
(54, 94, 170, 176, 220). Interestingly, lamin A, pUL31, and pUL34 are phosphorylated 
by the US3 kinase, and the kinase activity is required for smooth localization of the 
UL31/UL34 complex throughout the nuclear rim of infected cells (46, 71, 91, 100). 
Otherwise, the UL31/UL34 complex accumulates aberrantly in discrete foci located at 
the nuclear rim. At least some of these foci are adjacent to areas of the perinuclear 
space in which virions accumulate.  
How the pUL31/pUL34 complex is targeted to budding sites at the INM is an im-
portant but unresolved question. Host proteins are sufficient for targeting the complex 
to the INM because transiently expressed pUL31 and pUL34 are cotargeted to the nu-
clear rim in the absence of other viral proteins (79, 107). A current model proposes 
that most INM-destined integral membrane proteins in the endoplasmic reticulum use 
a subset of cytosolic nuclear localization signals to target them past the nuclear pore 
membrane to the INM via a karyopherin β1-driven pathway (26, 34). The proteins 
then become anchored to the INM by interaction with relatively immobile elements of 
the nuclear lamina (50). The nuclear lamina comprises a complex network of proteins 
that line the entire nucleoplasmic surface of the INM, structurally support the nucleus, 
and interact with chromatin (72). Intermediate filaments made of proteins called 
lamins comprise the major structural component of the nuclear lamina (59, 118). 
Lamins consist of two types, designated A and B. An alternatively spliced version of 
lamin A produces lamin type C that has a unique carboxyl terminus (59). Lamin B is 
expressed from two homologous genes, which encode lamin B1 and lamin B2 (76, 77). 
We previously showed that both pUL31 and pUL34 interact with lamin A produced in 
rabbit reticulocyte lysates, suggesting that this interaction might play a role in anchor-
ing pUL31/pUL34 to the INM (162).  
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 The main goal in initiating the current work was to test whether lamins are re-
quired for targeting of the pUL31/pUL34 complex to the inner nuclear membrane. 
Materials and methods 
Cells and viruses. Wild-type virus HSV-1(F) and a mutant HSV-1(F), containing 
a lysine-to-alanine mutation in US3 codon 220 (K220A), have been described and were 
obtained from B. Roizman and R. J. Roller, respectively. The viruses were grown and 
titers were determined on Vero cells as described previously.  
Hep2 cell lines engineered to express green fluorescent protein (GFP) fused to the 
N terminus of lamin A/C have been described previously (128). An immortalized 
lamin A/C knockout mouse embryonic fibroblast (MEF) cell line lacking the gene en-
coding lamin A/C (Lmna–/–) was a gift from Colin Stewart, NIH (201). To enhance cell 
adherence, Lmna–/– cells were propagated on cultureware pretreated with poly-L-lysine 
before seeding. Control MEFs (3T3) were obtained from Robert Weiss (Cornell Uni-
versity). This treatment precluded adherence of lamin B1 knockout MEFs (Lmnb1–/–), 
and corresponding wild-type MEFs (Lmnb1+/+) were a generous gift from Karen Reue 
and have been described elsewhere (217). Pretreatment with poly-L-lysine precluded 
adherence of these cells and was not used in their propagation. All MEFs were grown 
in growth medium (Dulbecco's modified Eagle's medium supplemented with 10% fetal 
bovine serum and antibiotics), except that the Lmnb1–/– MEFs and their control wild-
type cells were supplemented with additional nonessential amino acids (Gibco) and 
Glutamax (Gibco).  
Antibodies and immunofluorescence. Polyclonal chicken antibody against 
pUL34 was a kind gift of Richard Roller and has been described elsewhere (173). Puri-
fied polyclonal chicken immunoglobulin Y (IgY) directed against lamin A/C was made 
70 
 in our laboratory and has been published previously (162). Mouse monoclonal anti-
body directed against lamin A/C and goat polyclonal IgG directed against lamin B 
were purchased from Santa Cruz Biotechnology (catalog numbers sc-7292 and sc-
6216, respectively).  
For immunofluorescence, MEFs grown on glass coverslips were infected with 5.0 
PFU of wild-type HSV-1(F) or US3(K220A) HSV-1 per cell. Thirteen hours later, cells 
were fixed with 3% paraformaldehyde in phosphate-buffered saline (PBS) for 20 min, 
quenched with 50 mM NH4Cl for 15 min, and then permeabilized with 0.1% Triton X-
100. Nonspecific immunoreactivity was blocked by reaction with 10% human serum 
in PBS for 1 hour at room temperature and another 1 hour with 10% BlockHen II 
(Aves Lab). The cells were then reacted with anti-pUL34 chicken IgY diluted 1:400 
and goat polyclonal anti-lamin B antibody diluted 1:100 in PBS plus 1% bovine serum 
albumin for 1 h at room temperature as needed. Bound primary antibodies were recog-
nized by Texas Red- or fluorescein isothiocyanate-conjugated anti-immunoglobulins 
(Jackson ImmunoResearch).  
One-step viral growth curves. Lmna–/– and 3T3 MEFs grown in 12-well plates 
pretreated with poly-L-lysine were infected with 5 PFU of HSV-1(F) or US3(K220A) 
HSV-1 per cell. After 1 h of incubation at 37°C, residual surface infectivity was inac-
tivated with a low-pH wash (40 mM citric acid [pH 3.0], 10 mM KCl, 135 mM NaCl). 
A similar approach was used for the lamin B knockout cells and 3T3 control MEFS 
infected in parallel, except that cultureware was not pretreated. At the indicated time 
points, the cultures were frozen and thawed to lyse the cells, and infectious virus was 
titrated by plaque assay on Vero cells. Mean values of two independent experiments 
and corresponding standard deviations were calculated and plotted.  
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 GST pull-down assay and mass spectrometry. Approximately 4 x 108 Hep2 
cells were infected with 5 PFU/cell of wild-type HSV-1(F). At 16 h postinfection the 
cells were lysed in 30 ml modified radioimmunoprecipitation assay buffer {50 mM 
Tris-HCl [pH 7.4], 150 mM NaCl, 1% 3-[(3-cholamidopropyl)-dimethylammonio]-1-
propanesulfonate, 0.5% Na-deoxycholate, 0.1% sodium dodecyl sulfate [SDS], 1 mM 
EDTA} containing 1x Complete protease inhibitor cocktail (Roche) and phosphatase 
inhibitor (10 mM NaF, 10 mM Na3VO4) with gentle rocking for 2 h at 4°C. The lysate 
was clarified by centrifugation at 10,000 x g for 20 min at 4°C, and the supernatant 
was reacted with glutathione-Sepharose beads (GE) at 4°C. A glutathione S-transferase 
(GST)-pUL34 fusion protein was affinity purified from lysates of Escherichia coli us-
ing glutathione-Sepharose beads as described previously (162). The fusion protein was 
then covalently cross-linked to the Sepharose beads by reaction with 5 mM 
bis(sulfosuccinimidyl)suberate (Pierce) according to the manufacturer's protocol. GST 
identically cross-linked to Sepharose beads served as a control. After overnight incu-
bation of the precleared HSV-infected cell lysate with the protein-Sepharose beads 
bearing GST or GST-pUL34 at 4°C, the beads were washed two times with ice-cold 
modified radioimmunoprecipitation assay buffer and then three times with 0.5% 
Tween 20-PBS. The bound proteins were eluted by boiling for 10 min in SDS-
polyacrylamide gel electrophoresis sample buffer (10 mM Tris-HCl [pH 8.0], 10 mM 
β-mercaptoethanol, 20% glycerol, 5% SDS, trace amounts of bromophenol blue). The 
eluted proteins were then separated electrophoretically on a 10% polyacrylamide gel 
(SDS-polyacrylamide gel electrophoresis) and visualized by Sypro ruby staining. 
Bands overrepresented in the pUL34-GST pull-down relative to that with GST were 
excised and submitted for mass spectrometric analysis at the Biotechnology Resource 
Center, Cornell University, where the proteins in the gel were digested by trypsin and 
the masses of derived peptides determined by liquid chromatography-mass spectrome-
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 try (LC-MS). Peptides were identified by comparison to the NCBI Human database 
using MASCOT software (Matrix Science).  
In separate experiments, the GST-pUL34 fusion protein bound to glutathione-
Sepharose beads was reacted with lysates of uninfected Hep2 cells, and proteins bound 
to the beads were eluted, electrophoretically separated, and identified by LC-MS as 
described above.  
Immunoblotting. Nitrocellulose sheets bearing proteins of interest were blocked 
in 5% nonfat milk plus 0.2% Tween 20 for at least 2 hrs. The membrane was then 
probed with lamin A/C mouse monoclonal antibody. Primary antibody was detected 
by horseradish peroxidase-conjugated bovine anti-mouse secondary antibody (Santa 
Cruz Biotechnology). All bound immunoglobulins were visualized by enhanced 
chemiluminescence (Pierce) followed by exposure to X-ray film. Signals were quanti-
fied using NIH Image software.  
Conventional and immunogold electron microscopy. Cells were fixed with 4% 
paraformaldehyde (Electron Microscopy Sciences) and 0.25% glutaraldehyde (Elec-
tron Microscopy Sciences) in 0.1 M sodium phosphate buffer, pH 7.4, for 30 min at 
room temperature and then 90 min at 4°C. Cells were washed three times for 5 min 
each with the same buffer and then dehydrated with a graduated series of ethanol con-
centrations (10%, 30%, 50%, 70%, and 100%) at 4°C and then –20°C. This was fol-
lowed by stepwise infiltration with LR-White resin (catalogue no. 14381; Electron Mi-
croscopy Sciences) over the course of 48 h at –20°C. Samples were dispensed into gel 
capsules, and the resin was polymerized at 50°C for 18 h. Thin sections (60 to 90 nm 
thick) were collected on 300-mesh nickel grids (Ted Pella, Inc., Redding, CA) and 
floated on drops for the following procedures.  
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 For electron microscopic immunostaining, grids were blocked with 10% normal 
goat serum and 10% human serum in PBS-0.05% Tween (PBST) and 1% fish gelatin 
for 15 min at room temperature and were incubated on drops of pUL34-specific 
chicken antibody diluted 1:100 in PBST plus 1% fish gelatin for 3 h in a humidity 
chamber at room temperature. After incubation, grids were washed by brief passage 
over a series of 3 drops in a high-salt buffer (phosphate-buffered 750 mM NaCl, 
0.05% Tween, and 1% fish gelatin) and then 5 drops of 1x PBST and fish gelatin. The 
secondary antibody, donkey anti-chicken immunoglobulin conjugated with 12-nm col-
loidal gold, was diluted 1:100 in PBST-1% fish gelatin and reacted for 1 h in a humid-
ity chamber at room temperature. The grids were then washed as before on 6 succes-
sive drops of PBST-1% fish gelatin and then rinsed in a beaker of 200 ml of filtered 
water. Grids were air dried at room temperature prior to staining with 2% aqueous 
uranyl acetate for 20 min and then Reynolds lead citrate for 7 min. Stained grids were 
viewed in a Philips 201 transmission electron microscope. Conventionally rendered 
negatives of electron microscopic images were scanned by using a Microtek Scan-
maker 5 and Scanwizard Pro PPC 1.02 software. Positive images were rendered from 
digitized negatives with Adobe Photoshop software.  
Conventional electron microscopy was performed as above except that the cells 
were fixed in 2.5% glutaraldehyde in 0.1 M Na-cacodylate pH 7.4, followed by 2% 
OsO4 and embedded in Epon-Araldyte resin (EM Sciences). 
Results 
GST-pUL34 interacts with lamins A and B1 in infected cell lysates. To iden-
tify interaction partners that associated with pUL34, GST or GST fused to the N termi-
nus of full-length pUL34 (GST/pUL34) was affinity purified from Escherichia coli 
cells. Lysates of uninfected Hep2 cells or Hep2 cells infected with wild-type HSV-1(F) 
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 were then reacted with GST or the GST/UL34 fusion protein bound to glutathione-
Sepharose beads. Proteins were eluted from the beads in SDS sample buffer, electro-
phoretically separated on an SDS-polyacrylamide gel, and stained with Sypro ruby. 
Bands specifically emphasized or unique to the GST/pUL34 reactions as opposed to 
reactions with GST alone were excised and digested with trypsin, and the masses of 
peptides were determined by LC-MS. Within a protein band from infected cell lysates 
corresponding to approximately 70,000 apparent Mr, the masses of 12 tryptic peptides 
matched tryptic peptides predicted for human lamin A (Table 3.1). Moreover, a band 
containing protein of an apparent Mr of 75,000 from uninfected Hep2 cells contained 
five peptides consistent with human lamin B1. These data indicate that pUL34 interacts 
with lamin A/C and lamin B1 in cellular lysates. Although we cannot exclude the pos-
sibility that this interaction is indirect, the result combined with our previous observa-
tions showing that lamin A and pUL34 interact in rabbit reticulocyte lysates argue for a 
direct interaction (162). 
To determine whether lamin A/C and lamin B1 were specifically pulled down by 
GST/pUL34, the material pulled down by pUL34/GST and GST alone was electropho-
retically separated on SDS-polyacrylamide gels, transferred to nitrocellulose, and 
probed with either mouse monoclonal antibody directed against lamin A/C or goat 
polyclonal antibody directed against lamin B (see Materials and Methods). As shown 
in Fig. 3.1, although some lamin A/C and B1 was bound to Sepharose beads bearing 
GST alone, the presence of GST-pUL34 increased the amount of bound lamin A and 
B1 approximately by five fold as revealed by densitometry. In contrast, lamin C was 
not overrepresented in the GST/pUL34 pull down, despite the fact that lamins A and C 
were present in roughly equal amounts in the infected cell lysate. These data confirm 
the specificity of the interaction between pUL34 and lamins A and B1 in cellular lys-
ates and suggest that lamin C is not bound by GST/pUL34. 
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Table 3.1 Mass spectrometric parameters of lamin tryptic peptides from 
GST/pUL34 pull-down assays. 
Protein Exp-m/za Exp-Mrb Calc-Mrc Peptided 
415.7389 829.4633 829.4909 LQLELSK 
514.7929 1027.5712 1027.5662 LADALQELR 
544.6882 1087.3619 1088.5462 SLETENAGLR 
574.8158 1147.617 1147.5721 ITESEEVVSR 
594.3728 1186.731 1186.6306 LRDLEDSLAR 
680.3711 1358.7277 1358.679 SGAQASSTPLSPTR 
754.3094 1506.6042 1506.7348 TALINSTGEEVAMR 
783.8828 1565.7511 1565.7434 SVGGSGGGSFGDNLVTR 
535.6269 1603.8589 1604.8046 VAVEEVDEEGKFVR 
546.0125 1635.0156 1634.8297 TALINSTGEEVAMRK 
567.3505 1699.0295 1698.9628 IRIDSLSAQLSQLQK 
gi|27436946 
Lamin A/C 
isoform 1 
precursor 
[Homo 
sapiens] 
585.0183 1752.0331 1751.855 NSNLVGAAHEELQQSR 
485.34 968.66 968.48 IGDTSVSYK 
577.88 1153.74 1153.61 AGGPTTPLSPTR 
455.29 1817.14 1816.92 SLETENSALQLQVTER 
gi|5031877 
Lamin B1 
[Homo 
sapiens] 407.28 2031.36 2031.01 LAQALHEMREQHDAQVR 
 
a Mass-to-charge ratio (m/z) of experimental peptide.  
b Mr of experimental tryptic peptide.  
c Calculated Mr of lamin peptide from database.  
d Amino acid sequence of matching peptide. 
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Figure 3.1 Immunoblots of lamin A/C and lamin B pulled down by GST and 
GST/pUL34. Full-length pUL34 fused to GST or GST alone on glutathione-
Sepharose beads was reacted with HSV-1(F)-infected (A) or uninfected Hep2 
cell (B) lysates, respectively. Proteins bound to GST fusion proteins were eluted 
and electrophoretically separated on SDS-polyacrylamide gels, transferred to 
nitrocellulose, and probed with either a mouse monoclonal antibody against 
lamin A/C (A) or goat polyclonal antibody against lamin B (B). Bound immu-
noglobulin was revealed by reaction with appropriate horseradish peroxidase-
conjugated secondary antibodies followed by enhanced chemiluminescence. The 
signal intensities of protein bands were quantified and compared using Image J 
software, and the relative intensities of individual bands are indicated below cor-
responding lanes. 
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 Lamin A/C is required for the proper distribution of pUL34 in infected 
mouse embryonic fibroblasts. Given the above data suggesting that lamin A and 
pUL34 interact in infected cells, we wanted to determine whether the pUL34-lamin A 
interaction was involved in targeting pUL34 to the nuclear membrane. To test this hy-
pothesis, immortalized Lmna–/– MEFs or immortalized MEFs were infected with wild-
type HSV-1(F), and the localization of pUL34 was determined by indirect im-
munofluorescence and confocal microscopy. To assess nuclear shape, the cells were 
also immunostained with antibody directed against lamin B.  
Preliminary experiments indicated that cytopathic effects consequential to HSV 
infection were accentuated in Lmna–/– MEFs as opposed to wild-type MEFs. Specifi-
cally, many Lmna–/– MEFs underwent dramatic rounding upon infection and subse-
quently detached from the culture dish by 14 h after infection. By 16 h postinfection, 
the Lmna–/– MEF nuclei were highly distorted in shape, with irregular pUL34 staining 
in punctate foci that associated with the nuclear rim (data not shown). Because the ex-
aggerated changes in nuclear shape at late times after infection might affect pUL34-
specific localization indirectly, the cells were fixed at 13 hours postinfection when ef-
fects on nuclear shape were less prominent. The cells were then permeabilized and 
immunostained with antibodies directed against pUL34 and lamin B. The results are 
shown in Fig. 3.2.  
Optical slices recorded from points midway between the top and adherent surface 
of the cells revealed that pUL34-specific immunostaining localized at the nuclear rim 
of Lmna–/– cells, despite the absence of lamin A. On the other hand, the smooth dis-
tribution of pUL34 seen in infected MEFs was not observed in cells lacking lamin A/C. 
Rather, considerable areas of the nuclear rim of Lmna knockout cells were stained 
with lamin B-specific antibody but lacked detectable pUL34-specific immunostaining. 
Other regions of the nuclear rim contained areas with intense pUL34 immunostaining,
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Figure 3.2 Indirect immunofluorescence localization of pUL34 in HSV-1 in-
fected MEFs containing or lacking lamin A/C. Control MEFs or Lmna–/– 
MEFs were infected with either wild-type HSV-1(F) (A to F) or US3 kinase-dead 
mutant virus (K220A) (G to L). At 13 h postinfection, cells were fixed in para-
formaldehyde and immunostained for lamin B (green) and pUL34 (red) and visu-
alized by confocal microscopy. Optical sections for display were taken through a 
point between the top and bottom of cells. Insets contain magnified regions de-
limited by white rectangles in the same panel.
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 and these regions often overlapped lamin B immunostaining. We conclude that while 
lamin A/C is dispensable for localization of pUL34 at the nuclear rim, its presence is 
required for the normal smooth localization of pUL34 around the nuclear rim.  
Given that lamin A/C was required for the normal distribution of pUL34 through-
out the nuclear rim, we next wanted to determine whether lamin A/C was necessary 
for localization of pUL34 at the INM. To test this possibility, Lmna–/– or wild-type 
MEFs were infected with HSV-1(F), and thin sections of the infected cells were re-
acted with pUL34-specific IgY followed by reaction with 12-nm colloidal gold-
conjugated anti-IgY. As shown in Fig. 3.3, pUL34-specific immunoreactivity was as-
sociated with both the inner and outer nuclear membranes of both cell types (Fig. 3.3A 
to C). We therefore conclude that lamin A/C is not required for targeting pUL34 to the 
INM. 
To determine the effects of lamin A/C on HSV-1 replication, Lmna−/− and wild-
type MEFs were infected with 5.0 PFU/cell of wild-type HSV-1(F), and the virus in-
fectivity was measured at various times after infection. The results, shown in Fig. 3.4, 
indicated very little difference in the amount of infectious virus produced from the two 
cell types at all time points. Thus, lamin A/C neither enhanced nor hindered produc-
tion of wild-type HSV-1(F), at least at high multiplicities of infection. 
Effects of US3 kinase activity on viral infectivity and localization of pUL34 in 
the presence and absence of lamin A/C. The US3 kinase phosphorylates lamin A/C 
and pUL34, promotes production of infectious virus, and optimizes nuclear egress of 
virions. To determine whether the effects of US3 kinase activity on nuclear egress and 
pUL34 localization were dependent on lamin A/C, Lmna−/− or wild-type MEFs were 
infected either with a virus containing a mutation in US3 (K220A) that precludes 
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Figure 3.3. Ultrastructural localization of pUL34 in MEFs or Lmna–/– MEFs 
infected with HSV-1(F) or US3 kinase-dead virus. (A) Wild-type MEFs were 
infected with HSV-1(F), and localization of pUL34 was determined by reaction 
with pUL34-specific IgY followed by reaction with anti-chicken immunoglobu-
lin conjugated to 12-nm colloidal gold. Arrows indicate positions of gold beads 
indicative of pUL34 localization. (B and C) An experiment similar to that in 
panel A, except that Lmna–/– MEFs were used. Colloidal gold beads are present 
on the INM and are indicated by arrows. (D) Immunogold localization of pUL34 
in MEFs infected with the US3 kinase-dead virus. Insets show increased magni-
fications of the boxed areas and presence of colloidal gold beads on the INM and 
perinuclear virions. (E and F) Conventionally fixed images of MEFs infected 
with US3 kinase-dead virus showing virions within pouches of nuclear mem-
brane. (G) Immunogold localization of pUL34 in Lmna–/– cells infected with US3 
kinase-dead virus. Arrows show round extensions of the nuclear membrane 
emanating into the cytoplasm. The inset shows a negative image of a higher 
magnification of the boxed area and contains an extension of the INM heavily 
decorated with pUL34-specific gold beads. The image is displayed as a negative 
to more clearly demonstrate the gold beads in white. Despite the presence of 
pUL34, neither virions nor nucleocapsids accumulated within the extensions of 
nuclear membrane. 
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 kinase activity or with wild-type HSV-1(F) virus. As shown in Fig. 3.2G to L, and 
consistent with results from other cell lines, both cell types exhibited a distribution of 
pUL34 that differed from that of cells infected with the virus expressing active US3 
kinase. Specifically, pUL34 localized in punctate regions at the nuclear rim, as op-
posed to the more diffuse distribution seen in the presence of US3 kinase activity. On 
the other hand, the position of the pUL34-containing foci in Lmna−/− cells was most 
often on the cytoplasmic side of the nuclear rim, whereas these foci were located 
mostly on the nucleoplasmic side of the nuclear rim in normal MEFs. The latter distri-
bution resembled pUL34 localization in other cell lines examined previously (174). 
Thus, although lamin A/C is not required for the punctate distribution of pUL34 at the 
nuclear rim of cells infected with the US3 kinase-dead virus, it is required to retain 
these pUL34-containing foci within the nucleoplasm.  
To more precisely analyze the effects of US3 kinase activity on virion egress in 
the presence or absence of lamin A/C, thin sections of Lmna knockout MEFs and 
normal MEFs infected with wild-type and US3 kinase-dead viruses were examined by 
electron microscopy. As shown in Fig. 3.3D, virions accumulated aberrantly in pock-
ets of nuclear membranes of cells infected with the US3 kinase-dead virus in normal 
MEFs. In most cases, these virion-containing regions were located internal to the nu-
clear rim. The appearance of infected lamin A knockout cells differed substantially in 
three respects. First, membranous structures that appeared to represent extensions of 
the INM were often observed (Fig. 3.3G and inset). Secondly, the space between the 
INM and ONM was often exaggerated relative to uninfected cells and cells infected 
with wild-type HSV-1(F). Third, virions were not observed to accumulate to a large 
extent in the perinuclear space, even upon infection with the US3 kinase-dead virus. 
We conclude that lamin A is required for (i) the accumulation of virions in discrete 
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 regions of the perinuclear space normally seen in cells infected with the US3 kinase-
dead virus and (ii) the morphology of the INM normally seen in infected cells. 
To determine whether the concentrations of pUL34 as revealed by immunofluo-
rescence reflected localization of pUL34 within the extensions of the INM observed in 
Lmna knockout cells, we performed immunogold electron microscopy on these cells 
infected with the US3 kinase-dead virus. Whereas immunoreactivity with pUL34-
specific antibody was not detected in any cell line infected with the UL31 null virus 
(data not shown), extensions of INM were heavily decorated with gold beads reflect-
ing the localization of pUL34 (Fig. 3.3G, inset). Thus, pUL34 localization in nuclear 
membrane extensions correlated with the punctate distribution of Lmna knockout cells 
infected with the US3 kinase-dead virus. 
To determine the effects of lamin A/C and US3 kinase activity on viral infectivity, 
Lmna−/− MEFs or wild-type MEFs were infected with US3(K220A) or HSV-1(F) virus 
at 5.0 PFU/cell. At various times after infection the cells were lysed and the amount of 
infectious virus was determined by plaque assay on Vero cell monolayers. As shown 
in Fig. 3.4, the amount of virus produced by US3(K220A) was reduced by at least 10-
fold at all times relative to the amount produced by HSV-1(F) regardless of whether 
the cells produced lamin A/C or not. Perhaps the most striking effect, as noted in pre-
vious studies (164, 174), was a delay in the onset of production of infectious virus in 
the absence of US3 kinase activity, resulting in a reduction in viral titer by more than 
1,000-fold at 6 h postinfection. This delay occurred whether or not lamin A/C was 
produced. These data indicate that US3 kinase activity enhances both early and late 
production of infectious virus independently of its effects on lamin A/C. 
Pertaining more to the purposes of this report was the observation that infection 
of Lmna−/− cells with the US3(K220A) virus yielded approximately 10-fold more in-
fectious virus at 12 h postinfection relative to the amount produced in wild type MEFs.
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Figure 3.4 One-step growth curve of HSV-1 on normal MEFs or Lmna–/– 
MEFs. Cells were infected with either HSV-1(F) or US3(K220A) at 5 PFU per 
cell. Residual infectivity was inactivated by a low-pH wash at 1 hour postinfec-
tion. At the indicated time points, the whole culture was collected, virus was re-
leased by freeze-thawing, and infectivity was titrated on Vero cells. Experiments 
were performed in duplicate. Mean values are plotted, and standard deviations 
are represented by error bars.
 The discrepancy in titer decreased later in infection, such that at 18 and 24 h after in-
fection infectious virus produced by the Lmna knockout cells was increased only five-
fold and threefold, respectively, over that obtained from normal MEFs. These data in-
dicate that expression of lamin A/C decreases production of infectious virus and that 
US3 kinase activity partially relieves the lamin A/C-dependent impediment to viral 
replication. 
Lamin B1 is dispensable for localization of pUL34 to the nuclear rim but is 
required for normal viral growth. As shown in Table 3.1 and noted above, peptides 
in the pUL34/GST pull-down assay were consistent with the predicted masses of tryp-
tic peptides derived from four different regions of lamin B1. To determine whether the 
interaction between pUL34 and lamin B was specific, the proteins pulled down with 
pUL34/GST or GST were subjected to immunoblotting with lamin B-specific anti-
body. As shown in Fig. 3.1B, lamin B-specific immunoreactivity was readily detected 
in the pUL34/GST pull-down assay, confirming the mass spectrometric analysis. 
Moreover, densitometry revealed that fivefold less immunoreactivity was detected in 
the material pulled down with GST. Thus, we conclude that the interaction with lamin 
B1 was specific, although we could not exclude the possibility that the interaction was 
indirect.  
Given the potential interaction between pUL34 and lamin B1, we determined 
whether lamin B1 plays a role in localization of pUL31 and pUL34 to the nuclear 
membrane by using a similar strategy as employed in the study of lamin A. Thus, 
MEFs lacking lamin B1 were obtained and infected with 5.0 PFU HSV-1(F) or 
US3(K220A) per cell, and the localization of pUL34 was determined by indirect im-
munofluorescence 13 h later. As shown in Fig. 3.5, and unlike the effects caused by 
the absence of lamin A/C, the distribution of pUL34-specific immunostaining in the
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Figure 3.5 Confocal indirect immunofluorescence determination of the dis-
tribution of pUL34 in HSV-1 infected MEFs containing or lacking lamin B1. 
Wild-type MEFs (A and C) or Lmnb1–/– MEFs (B and D) were infected with 
HSV-1(F) or Us3(K220A) virus, fixed at 13 h postinfection, and immunostained 
for pUL34 as described in the legend to Fig. 2. The green channel and transmit-
ted light from optical sections were taken near the middle of infected cells and 
digitally superimposed for illustrative purposes. The unaltered image was then 
converted to grayscale in Adobe Photoshop. Bar, 10 µM (upper panels) or 15 
µM (lower panels). 
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 lamin B knockout cells was not visibly altered from that seen in wild-type MEFs. On 
the other hand, HSV-induced cytopathic effects were accentuated in the lamin B1 
knockout cells compared with infected normal MEFs. The alteration in cell morphol-
ogy as a consequence of virus infection was severe enough to pose difficulties in 
maintaining the lamin B knockout cells on coverslips late after infection (data not 
shown). 
To determine the effects of the US3 kinase on distribution of pUL34 in the ab-
sence of lamin B1, the Lmnb1 knockout cells and wild-type MEFs were infected with 
the US3(K220A) virus and the localization of pUL34 was determined by indirect im-
munofluorescence. As shown in Fig. 3.5, pUL34 localized in a similar punctate distri-
bution at the nuclear rim of both cell lines. On the other hand, the foci in the lamin B1 
knockout cells appeared less numerous than those observed in the wild-type MEFs in-
fected with the US3 kinase-dead virus.  
As shown in Fig. 3.6C, D, and E, representative electron microscopic images of 
many cells examined revealed that, unlike the case in the lamin A knockout cells, 
lamin B1 knockout cells infected with the US3 kinase-dead virus contained regions of 
nuclear membrane bearing virions. A feature unique to these cells infected with this 
virus was the presence of very densely staining scalloped-shaped extensions of what 
appeared to be the nuclear membrane (Fig. 3.6D and E). These observations taken to-
gether with the indirect immunofluorescence studies indicate that lamin B1 is dispen-
sable for targeting of pUL34 to the nuclear rim of infected MEFs, but it is required for 
normal nuclear membrane morphology of cells infected with the US3 kinase-dead vi-
rus. 
Immunogold electron microscopy experiments were also performed to determine 
the localization of pUL34 in the lamin B1 knockout cells. As shown in Fig. 3.6B, gold 
beads indicative of the localization of pUL34 localized at the nuclear rim of cells
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Figure 3.6 Localization of pUL34 in Lmnb1–/– cells infected with HSV-1(F) 
or US3(K220A) viruses. (A) Low magnification of an HSV-1(F)-infected cell. 
(B) Section of nuclear membrane of cell infected with HSV-1(F). Positions of 
gold beads indicative of pUL34 localization are indicated by arrows. (C) Low 
magnification of lamin B1 knockout MEF cell infected with US3 kinase-dead 
virus. (D and E) Higher magnification of cells infected with US3 kinase-dead 
virus, showing several gold beads associated with scalloped dense-staining nu-
clear membrane and perinuclear virions. As a size standard, capsids are 125 nm 
in diameter. 
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 infected with the wild-type virus. Moreover, pUL34-specific immunoreactivity was 
noted at the INM of lamin B1 knockout cells infected with the US3 kinase-dead mu-
tant. This immunostaining localized mostly within the densely staining, scallop-shaped 
regions of the nuclear membrane or was associated with nearby virions (Fig. 3.6D and 
E). These data therefore indicate that lamin B1 is dispensable for targeting pUL34 to 
the INM but necessary for the normal morphology of the nuclear membrane in the ab-
sence of US3 kinase activity.  
We next examined the effects of the absence of lamin B1 on viral infectivity in 
the presence and absence of the US3 kinase. As shown in Fig. 3.7, the lamin B1 
knockout cells were less permissive to HSV replication than normal MEFs, regardless 
of whether the US3 kinase was active. Specifically, titers at all time points in wild-type 
MEFs were at least 10-fold greater than those reached in the lamin B1 knockout cells 
infected with either wild-type virus or the US3 mutant virus. We therefore conclude 
that lamin B1 contributes substantially to the production of infectious virus, but this 
does not reflect a role in targeting pUL34 to the INM. 
Discussion 
Taken together, the data presented herein indicate that targeting of pUL34 to the 
INM and aggregation in the absence of US3 kinase activity are not dependent on ex-
pression of lamin A/C or B1, despite the observation that these proteins were shown to 
interact with pUL34 in infected cell lysates. On the other hand, the absence of lamin 
A/C altered the normal smooth distribution of pUL34 as revealed by indirect im-
munofluorescence, suggesting that it is directly or indirectly involved in pUL34 distri-
bution within the nuclear rim. In contrast, lamin B1 was entirely dispensable for pUL34 
targeting to the nuclear rim, as viewed by indirect immunofluorescence, and to the 
INM, as viewed by immunogold electron microscopy. Thus, lamin A or lamin A-
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Figure 3.7 Growth curves of HSV-1(F) or US3 kinase-dead virus in MEFs or 
Lmnb1–/– MEFs. The experiment was performed similarly to that described in the 
legend to Fig. 3.4. 
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 interacting components of the nuclear lamina are more relevant to pUL34 targeting 
than lamin B1 or lamin B1-interacting components. The effects of lamin A on pUL34 
targeting may reflect effects of lamin A on lamina mechanics and stiffness, function-
swhich are largely independent of lamin B1 (102). Alternatively, data obtained in this 
study and in previous work in which lamin A, pUL31, and pUL34 were shown to inter-
act in pull-down assays from rabbit reticulocyte lysates suggest that the lamin A-
pUL34 interaction is direct and may play a role in pUL34 targeting (162). The data are 
also consistent with the observation that emerin, a lamin A-interacting protein, can in-
teract with pUL34 and is displaced in HSV-infected cells in a pUL34-dependent man-
ner (103). Whether the emerin-pUL34 interaction is mediated through interactions with 
lamin A/C will require further studies. A final possibility is that lamin B1 is involved 
in INM targeting of pUL34, but lamin A confers redundant functions that compensate 
for the absence of lamin B1.  
An untested but widely accepted hypothesis is that the nuclear lamina poses a 
barrier that herpesviruses must breach to allow nucleocapsids access to the INM for 
envelopment. Along these lines, previous observations indicated that the lamina is dis-
rupted in HSV-infected cells in a pUL31/pUL34-dependent manner (15, 128, 162, 185, 
186). Several studies have identified mechanisms by which pUL31/pUL34 of HSV may 
accomplish nuclear lamina disruption. Specifically, protein kinase C-δ and -α have 
been shown to be recruited to the nuclear membrane in a pUL31/pUL34-dependent 
manner to augment lamin B phosphorylation, whereas US3 has been shown to phos-
phorylate lamin A directly in vitro and to be required for its optimal phosphorylation 
in infected cells (128, 146). Moreover, pUL31/pUL34 may have their own lamina-
depolymerizing activities inasmuch as overexpression of these proteins in the absence 
of other proteins is sufficient to disrupt the lamina, and locally high concentrations of 
pUL31/pUL34 exaggerate adjacent lamina perforations (15, 128, 162, 185). The obser-
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 vation in this study that lamin A knockout cells are more permissive to replication of a 
US3 kinase-dead virus at high multiplicities of infection further argues that at least 
lamin A poses a barrier to replication (and presumably nucleocapsid envelopment) and 
that US3 helps to overcome this barrier. Thus, disruption of the lamina might indeed 
reflect an important role for these proteins in promoting virion budding at the INM.  
Despite their relative permissiveness to virus replication at high multiplicities of 
infection, the lamin A knockout cells exhibited altered NM morphology when infected 
with the US3 kinase-dead virus. Specifically, exaggerated extensions of the INM and 
increased space between the INM and ONM were noted. Because these effects were 
precluded by US3 kinase activity, it follows that substrates of US3 kinase other than 
lamin A are responsible for these phenotypes. Previous studies reported increased 
spacing between the INM and ONM upon overexpression of UL34, pUL31/pUL34-
dependent alterations of the nuclear lamina, and budding from the INM upon coex-
pression of pUL31 and pUL34 of pseudorabies virus in the absence of capsids (93, 
236). Thus, the effects on nuclear membrane morphology induced by the combined 
absence of US3 kinase activity and lamin A might be consequential to increased con-
centration of pUL34/pUL31 in certain regions of the INM. This is consistent with the 
observation by immunogold electron microscopy that pUL34 was specifically detected 
in the unusual nuclear membrane extensions observed in this study.  
Also interesting to us was the absence of virions trapped within the perinuclear 
space of the Lmna knockout MEFs infected with the US3 kinase-dead virus, despite the 
fact that this feature was commonplace in similarly infected normal MEFs. Thus, 
lamin A is somehow required for the observed retention of virions in discrete regions 
within the perinuclear space. We speculate that this reflects the general permissivity of 
primary envelopment in the lamin A knockout cells. Thus, capsids may bud through 
the INM at multiple sites in the absence of lamin A, whereas the positions of envelop-
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 ment sites are more restricted by the lamin A-imposed barrier in normal MEFs. The 
absence of US3 kinase activity would still delay fusion of the virion envelope and 
ONM, but the wide dispersal of virions in the perinuclear space of Lmna knockout 
cells would preclude virion aggregation. Alternatively, we cannot rule out the possibil-
ity that the nuclear envelope is generally more fragile in the lamin A knockout cells, 
thus precluding stable association of virions within the perinuclear space of cells as 
they are pelleted prior to fixation for electron microscopy.  
We also noted that pUL34-containing regions mostly localized external to the nu-
clear membrane in lamin A knockout cells infected with the US3 kinase mutant but 
internal to the nuclear membrane in MEFs or lamin B1 knockout cells infected with 
this virus. We speculate that lamin A, by enhancing lamina stiffness, restrains locally 
high concentrations of the pUL31/pUL34 complex from inducing cytoplasmic protru-
sions of the nuclear membrane, although we cannot exclude more indirect mecha-
nisms.  
In striking contrast to the results with lamin A, Lmnb1 knockout MEFs were less 
permissive to viral replication at high multiplicities of infection, and this was observed 
in both the presence and absence of US3 kinase activity. The role of lamin B1 in HSV 
infection is unclear, but it is required for a number of important nuclear functions in-
cluding transcription, DNA replication, cell signaling, and optimal reassembly of the 
nucleus after mitosis (196). Thus, disturbance of any of these or related functions 
might render the cells less permissive by impairing the machinery that the virus ulti-
mately needs to commandeer for optimal infection. This may be one reason why al-
teration of the nuclear lamina during viral infection is mostly limited to very discrete 
regions. Such a strategy might limit detrimental effects on the cell while still allowing 
nucleocapsids to bud through the INM. 
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 Abstract 
Herpes simplex virus 1 (HSV-1) nucleocapsids bud through the inner nuclear 
membrane (INM) into the perinuclear space to obtain a primary viral envelope. This 
process requires a protein complex at the INM composed of the UL31 and UL34 gene 
products. While it is clear that the viral kinase encoded by US3 regulates the localiza-
tion of pUL31/pUL34 within the INM, the molecular mechanism by which this is ac-
complished remains enigmatic. Here, we have determined that (i) the N-terminus of 
pUL31 is indispensable for the protein’s normal function and contains up to 6 serines 
that are phosphorylated by the US3 kinase during infection. (ii) Phosphorylation at 
these 6 serines was not essential for productive infection, but was necessary for opti-
mal viral growth kinetics. (iii) In the presence of active US3 kinase, changing the seri-
nes to alanine caused the pUL31/pUL34 complex to aggregate at the nuclear rim and 
caused some virions to accumulate aberrantly in herniations of the nuclear membrane, 
much as in cells infected with a US3 kinase-dead mutant. (iv) Replacement of the 6 
serines of pUL31 with glutamic acid largely restored the smooth distribution of 
pUL34/pUL31 at the NM, and precluded the accumulation of virions in herniations 
whether or not US3 kinase was active, but also precluded optimal primary envelop-
ment of nucleocapsids. These observations indicate that phosphorylation of pUL31 by 
pUS3 represents an important regulatory event in the virion egress pathway that can 
account for much of pUS3’s role in nuclear egress. The data also suggest that the dy-
namics of pUL31 phosphorylation modulate both primary envelopment and subsquent 
fusion of the nascent virion envelope with the outer nuclear membrane. 
Introduction 
The UL31 and UL34 proteins of herpes simplex virus 1 (HSV-1) form a complex 
that locates at the inner nuclear membrane (INM) of infected cells (163, 164). This 
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 complex is essential for budding of nucleocapsids through the INM into the perinu-
clear space (163, 173). pUL34, an integral membrane protein with a 247 amino acid 
nucleoplasmic domain, binds pUL31 and holds the latter in close approximation to the 
INM (117, 163, 232, 235). Both proteins become incorporated into nascent virions in-
dicating they directly or indirectly interact with nucleocapsids during the budding 
event (164). Interestingly, co-expression of the pseudorabies virus homologs of HSV 
pUL31 and pUL34 are sufficient to induce budding from the INM in the absence of 
other viral proteins (91). 
The most prominent model of nuclear egress proposes that the step following 
primary envelopment involves fusion of the perinuclear virion envelope with the outer 
nuclear membrane (ONM), allowing subsequent steps in which the de-enveloped cap-
sid engages budding sites in the Golgi or trans-Golgi network (123, 194). The US3 
protein is a promiscuous kinase that phosphorylates pUL31, pUL34, and several other 
viral and cellular components (13, 14, 20, 89, 103, 128, 129, 152, 153, 156, 174). In 
the absence of pUS3 kinase activity (i) virions accumulate within the perinuclear 
space, often causing distensions of this space that herniate into the nucleoplasm (93, 
164, 174), (ii) the pUL31/pUL34 complex is mislocalized at the nuclear rim from a 
smooth pattern to discrete foci that accumulate adjacent to nuclear membrane herni-
ations and (iii) the onset of infectious virus production is delayed (128, 174). 
Aberrant accumulations of perinuclear virions similar to those observed in cells 
infected with US3 kinase-dead viruses have been observed in cells infected with vi-
ruses lacking the capacity to produce glycoproteins H and B (gH and gB, respectively) 
(56). Because these proteins are required for fusion with the plasma membrane or en-
docytic vesicles during HSV entry (3, 65, 161), it has been speculated that the accu-
mulation of perinuclear virions in the absence of gH and gB reflects a failure in the 
apparatus that normally mediates fusion between the nascent virion envelope and 
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 ONM. By extension of this hypothesis, pUS3 might act to trigger this perinuclear fu-
sion event. 
The substrate(s) of pUS3 kinase responsible for the altered localization of the 
pUL31/pUL34 complex and aberrant accumulation of perinuclear virions is unknown.  
In one study to identify such a substrate, it was determined that precluding phosphory-
lation of pUL34 was not responsible for the nuclear egress defects induced by the ab-
sence of pUS3 or its kinase activity (174). The current study was therefore undertaken 
to investigate the hypothesis that pUS3-mediated phosphorylation of pUL31 is critical 
to regulate nuclear egress. Evidence presented herein indicates that aspects of the US3 
kinase-dead phenotype, including retention of virions in the perinuclear space, mislo-
calization of the pUL31/pUL34 complex, and delayed onset of virus replication, can be 
replicated by precluding pUL31 phosphorylation in the presence or absence of pUS3 
kinase activity. The data also suggest that dynamic phosphorylation of pUL31 is im-
portant for efficient primary envelopment of nucleocapsids.  
Materials and methods 
Cells and viruses. Wild type virus HSV-1(F), UL31 null virus, and mutant virus 
containing a Lysine to Alanine mutation in US3 codon 220 (K220A), have been de-
scribed and were obtained from B. Roizman and R. J. Roller, respectively (24, 49, 
174). The HSV-1(F) and US3(K220A) viruses were propagated and titered on Vero 
cells, whereas the UL31 null virus was grown and titered on a UL31-expressing rabbit 
skin cells described previously (107). 
Plasmids. For transient expression, the UL31 gene was cloned into the pcDNA3 
vector (Invitrogen) or into the pBudCE4.1 vector (Invitrogen) with a FLAG epitopic 
tag on the 3’ end as indicated. Full length UL31 ORF in pcDNA3 was previously de-
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 scribed (163). The UL31-pcDNA3 then served as a template for other pcDNA3 or 
pBudCE4.1 constructs using PCR primers listed in Table 4.1. pGEX4T vectors (Am-
ersham) were used for GST fusion expression plasmids. The construction of GST 
fused to full length UL31 was also reported previously (163). Standard cloning meth-
ods were used to generate a series of GST fusion subclones. Briefly, UL31 sequences 
were amplified from HSV-1 (F) genomic DNA using the primers listed in Table 4.1. 
The amplicons were first ligated into the pCR2.1 vector (Invitrogen) using TA clon-
ing, and were flanked by EcoRI restriction sites as a result. The EcoRI fragments con-
taining UL31 sequences were subcloned into the EcoRI site of the pGEX4T vector 
(Amersham) in frame with the GST gene. To generate the point mutant plasmids, 
UL31 were amplified from the corresponding mutant viral BAC DNAs bearing such 
mutations (described below); these amplicons were then cloned into the pGEX4T vec-
tor at the EcoRI and XhoI sites. 
Recombinant viruses and BAC mutagenesis. A series of recombinant viruses 
were constructed using en passant mutagenesis of a bacterial artificial chromosome 
(BAC) containing the entire HSV-1(F) genome as previously described (205). Briefly, 
a PCR amplicon bearing fragments containing a Kan resistance cassette, Sce-I restric-
tion endonucleae site and desired mutations flanked by homologous regions to the tar-
get gene was generated with primer pairs listed in Table 4.2 and pEPkan-S plasmid as 
template. The resulting amplicons were electroporated into recombination competent 
GS1783 E. coli, which harbors the target BAC and a Sce1 endonuclease gene inte-
grated into its genome (a kind gift of Greg Smith). Following Kanamycin resistance 
screening and restriction length polymorphism (RFLP) confirmation, the KanR se-
quence was removed by RED recombination between internal homologous sequences 
that were generated through SceI cleavage, which was initiated by arabinose-induced
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 Table 4.1 Vectors and primers used to generate UL31 subclones (restriction sites 
used for cloning were underlined and Flag sequence was colored in red). 
Plasmids UL31 
codons 
Vectors Primers  
UL31(dN)-
pCDNA3 
AA 45-306 pcDNA3 5’-ATACTCGAGATGCCGCCTCAC 
G-3’ 
5’-TATACTCGAGCTACGGCGGAG 
GAAAC-3’ 
UL31-Flag AA 1-306 pBudCE 4.1 5’-ATACTCGAGACCTATGTATGA 
CACCGACCC-3’ 
5’-ATAAGATCTTACTTATCGTCGT 
CATCCTTGTAATCCGGCGGAGGA 
AACTC-3’ 
UL31(dN)-
Flag 
AA 45-306 pBudCE 4.1 5’-ATACTCGAGACCTATGCCGCC 
TCACG-3’ 
5’-ATAAGATCTTACTTATCGTCGT 
CATCCTTGTAATCCGGCGGAGGA 
AACTC-3’ 
GST-UL31 
(1-50aa) 
AA 1-50 pCR2.1 
pGEX4T-2 
5’-ATGTATGACACCGACCCCCAT 
C-3’ 
5’-TTTGCGGGCGTGAGGC-3’ 
GST-UL31 
(52-165aa) 
AA 52-165 pCR2.1 
pGEX4T-1 
5’-TCTCGAGATGGAGGAGCTGTG 
TTTAC-3’ 
5’-TCTAGGCCAACACGACCAA -3’ 
GST-UL31 
(159-265aa) 
AA 159-265 pCR2.1 
pGEX4T-1 
5’-GCTCGAGATGGTGGCCTCCTT 
GGTC-3’ 
5’-CCTAGTCCGTGGGTTTCTCTGC 
GTT-3’ 
GST-UL31 
(255-306) 
AA 259-306 pCR2.1 
pGEX4T-1 
5’-CCTCGAGATGGGCAACGCAGA 
GAAACC-3’ 
5’-CCTACGGCGGAGGAAACTC-3’ 
GST-
UL31(SA3) 
AA 1-306 pGEX4T-1 5’-TAGAATTCATGTATGACACCG 
ACCCCCATC-3’ 
5’-TATACTCGAGCTACGGCGGAG 
GAAAC-3’ 
GST-
UL31(SA6) 
AA 1-306 pGEX4T-1 5’-TAGAATTCATGTATGACACCG 
ACCCCCATC-3’ 
5’-TATACTCGAGCTACGGCGGAG 
GAAAC-3’ 
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 Table 4.2 Primers for BAC mutagenesis (introduced mutations were colored in 
red). 
BAC Primers 
UL31(dN) 5’-ATC TCG CTC CTG TCC CTG GAG CAC ACC CTG TGT 
ACC TAT GCC GCC TCA CGC CCG CAA ACA TAG GGA 
TAA CAG GGT-3’  
5’-GCT CGT GTA AAC ACA GCT CCT GTT TGC GGG CGT 
GAG GCG GCA TAG GTA CAC AGG GTG TGC GCC AGT 
GTT ACA ACC-3’ 
UL31(SA3) 5’-TCG ATC TCG CTC CTG TCC CTG GAG CAC ACC CTG 
TGT ACC TAT GTA TGA CAC CGA CCC CAT CGC CGC GGC 
GCC CGG CCC GGG CCC TAT CAC GGC AAG GAG CGC 
CGG CGG GCG CGC TCC TCT GCG GCC GGC GTA GGG 
ATA ACA GGG T-3’  
5’-GGC CCC GAT AGC GCT GGC GCT CGT GTA AAC ACA 
GCT CCT GTT TGC GGG CGT GAG GCG GCA GGC TCT TCC 
GGG CGG CCC GAC GCA CCA CGC CCA GAG TCC CGC 
CGG CCG CAG AGG AGC GCG CCC GCC GGC GCT CCT 
TGC CAG TGT TAC AAC C-3’ 
UL31(SA6) 5’-GCC CGG GCC CTA TCA CGG CAA GGA GCG CCG GCG 
GGC GCG CGC TGC TGC GGC CGG CGG GAC TCT GGG 
CGT GGT GCG TCG GGC CGC CCG GAA GTA GGG ATA 
ACA GGG T-3’ 
5’-CGT GTA AAC ACA GCT CCT GTT TGC GGG CGT GAG 
GCG GCA GTG CCT TCC GGG CGG CCC GAC GCA CCA 
CGC CCA GAG TCC CGC CGC CAG TGT TAC AAC C-3’ 
UL31(SAR) 5’-GGG CCT CCC GGA AGA GCC TGC CGC CTC ACG CCC 
GCA AAC AGG AGC TGT GTT TAC ACG AGC TAG GGA 
TAA CAG GGT-3’  
5’-GCT CGT GTA AAC ACA GCT CCT GTT TGC GGG CGT 
GAG GCG GCA TAG GTA CAC AGG GTG TGC GCC AGT 
GTT ACA ACC-3’ 
Amplicon generated using above primers were PCR fused with a 
second amplicon generated from wild type HSV-1 (F) genomic 
DNA with primer pair 5’-tgcatagcgttgcgtgcc-3’ and 5’-tttgcgggcgt 
gaggc-3’ to obtain the 5’ extension required for homologous recom-
bination. 
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Table 4.2 (Continued) 
BAC Primers 
UL31(SAE) 5’-CCC GGG CCC TAT CAC GGC AAG GAG CGC CGG CGG 
GCG CGC GAA GAA GCG GCC GGC GGG ACT CTG GGC 
GTG GTG CGT CGG GCC GCC CTA GGG ATA ACA GGG T-3’ 
5’-GTG TAA ACA CAG CTC CTG TTT GCG GGC GTG AGG 
CGG CAG TTC CTT CCG GGC GGC CCG ACG CAC CAC GCC 
CAG AGT CCC GCC GGC CGC CAG TGT TAC AAC C-3’ 
UL31(SE6) 5’-TCG ATC TCG CTC CTG TCC CTG GAG CAC ACC CTG 
TGT ACC TAT GTA TGA CAC CGA CCC CAT CGC CGC GGC 
GAA CGG CCC GGG CCC TAT CAC GGC AAG GAG CGC 
CGG CGG GAA CGC GAA GAA GCG GCC GGC GTA GGG 
ATA ACA GGG T-3’  
5’-GGC CCC GAT AGC GCT GGC GCT CGT GTA AAC ACA 
GCT CCT GTT TGC GGG CGT GAG GCG GCA GTT CCT TCC 
GTT CGG CCC GAC GCA CCA CGC CCA GAG TCC CGC 
CGG CCG CTT CTT CGC GTT CCC GCC GGC GCT CCT TGC 
CAG TGT TAC AAC C-3’ 
UL31(SE6)/ 
US3(K220A) 
5’-TGA CAG CAG CCA TCC AGA TTA CCC CCA ACG GGT 
AAT CGT GGC GGC GGG GTG GTA CAC GAG CAT AGG 
GAT AAC AGG GTA ATC GAT TT-3’ 
5’-CAG TCG CGC CTC GTG GCT CGT GCT CGT GTA CCA 
CCC CGC CGC CAC GAT TAC CCG TTG GGG GTG CCA GTG 
TTA CAA CCA ATT AAC C-3’ 
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 SceI expression in GS1783 E. coli. Positive clones were verified through Kanamycin 
selection and further by RFLP and DNA sequencing (not shown). Rabbit skin cells 
were transfected with the BAC and a plasmid encoding FRT recombinase to remove 
the BAC sequences as described previously (107). Viral plaques were propagated into 
viral stocks using Vero cells.  
All the BACs were designated according to their genotypes. Before obtaining the 
UL31(SA6) BAC, the sequence of the UL31 gene from 3 to 132 nucleotides was first 
deleted from wild type HSV-1 (F) BAC, producing an intermediate BAC designated 
UL31(dN). The deleted region bearing designed mutations was then inserted, thus 
changing codons 11, 24 and 40 from serine into alanine. The resulting BAC was 
named UL31(SA3), which then served as the parental BAC to generate UL31(SA6) 
BAC by changing serine codons 26, 27 and 43 to alanine. The repair BAC UL31(SAR) 
was created by repeating the deletion step starting with the UL31(SA6) BAC, thus re-
generating the intermediate UL31(dN) genotype, followed by insertion of wild type 
sequences. In a separate experiment, this UL31(dN) BAC served as the recipient of 
mutations changing codons 11, 24, 26, 27, 40 and 43 to those encoding glutamic acid. 
This BAC was designated BAC UL31(SE6). The UL31(SAE) BAC was derived from 
the BAC UL31(SA6) by mutating alanine codons 26, 27 and 43 into glutamic acid 
codons. Incorporation of mutations substituting lysine codon 220 of US3 with alanine 
in the UL31(SE6) BAC led to the double mutant BAC UL31(SE6)/Us3(K220A).  
In vitro US3 kinase assays.  A kinase assay was performed using purified GST-
pUS3 essentially as described previously (128). Briefly, 0.1 μg GST-pUS3 was incu-
bated separately with approximately 1 μg of pUL31-GST fusion proteins partially puri-
fied from E. coli and bound to glutathione Sepharose beads. The kinase reaction was 
performed for 30 minutes at 30oC in 50 μl pUS3 specific kinase buffer (50mM Tris 
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 [pH9.0], 20mM MgCl2, 0.1% NP40, 1mM DTT) containing 10 μM ATP and 10 μCi 
[γ-32P] ATP (Amersham). The Sepharose beads bearing the fusion proteins were then 
washed three times with TNE buffer (20 mM Tris-HCl [pH 8.0], 100 mM NaCl, 1 mM 
EDTA). The proteins were eluted in SDS-PAGE sample buffer (10 mM Tris-HCl [pH 
8.0], 10 mM β-mercaptoethanol, 20% glycerol, 5% SDS, trace amounts of bromophe-
nol blue)] and subjected to electrophoresis in a 12% polyacrylamide gel in the pres-
ence of 0.1% SDS. Gels were then stained with Coomassie brilliant blue, dried and 
autoradiographed using X-ray film (Pierce). 
Transient complementation assay. Hep2 cells were seeded at 90% confluence 
in 12 well plates and were transfected with 1.6 μg plasmid DNA using lipofectamine 
(Invitrogen). After 20 hr incubation at 37oC, the cells were infected with 5.0 PFU per 
cell of the UL31 null virus. At 24 hpi, whole cell cultures were lysed for viral titering 
on UL31 expressing rabbit skin cells. Experiments were performed in duplicate. Means 
and standard deviations were calculated and plotted. 
One-step viral growth assay. 100% confluent Vero cells grown in 12-well 
plates were infected with 5.0 PFU per cell of the indicated viruses. After 1 hr incuba-
tion at 37oC, residual surface infectivity was inactivated with a low-pH wash (40mM 
Citric Acid [pH 3.0], 10mM KCl, 135mM NaCl). At the indicated time points, the cul-
tures were frozen and thawed to lyse the cells, and infectious virus was titrated by 
plaque assay on Vero cells. The mean values of two independent experiments and cor-
responding standard deviations were calculated and plotted. 
Antibodies and Immunofluorescence assay. Polyclonal chicken antibody 
against pUL34 was a kind gift from R. J. Roller. Rabbit anti-pUL31 antisera were pre-
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 pared in our laboratory and was described previously (163). M2 mouse monoclonal 
antibody against the Flag epitopic tag was purchased from Sigma. 
Hep2 cells growing on glass coverslips were mock infected or were infected with 
the indicated viruses at an MOI of 5 PFU/cell for 16 hrs. Cells were fixed with 3% 
PFA for 15 min. In experiments where the pre-adsorbed pUL31-specific rabbit poly-
clonal antibody was to be used, the cells were treated for another 15 min at –20 C in 
methanol. The cells were then permeabilized with 0.1% Triton-X 100 and reacted with 
10% human serum in phospho-buffered saline (PBS) to block nonspecific immunore-
activity, and subsequently probed with the pre-adsorbed pUL31 antiserum diluted 1:50 
in PBS supplemented with 1 % BSA. Thereafter, 10% BlockHen II (Aves Lab) was 
used for a second round of blocking before probing with a 1:400 dilution of chicken 
anti-pUL34 polyclonal antibody. Bound primary antibodies were recognized by corre-
sponding secondary antibodies conjugated with FITC or Texas Red, respectively 
(Jackson ImmunoResearch). 
In some experiments, cells were transfected with equal amounts of UL31-
encoding plasmid DNA for 20 hrs prior to infection using lipofectamine (Invitrogen). 
Infected cells were processed for indirect immunofluorescence in the same way except 
that no methanol fixation was used, and the M2 anibody directed against the Flag epi-
tope was diluted 1:100. Images were visualized and recorded using an Olympus con-
focal microscope. Digital images were processed with Adobe Photoshop. 
Electron microscopy. Cells were first fixed with 2.5% glutaraldehyde in 0.1 M 
Na-cacodylate pH 7.4 (Electron Microscopy Sciences) for 30 min at room temperature 
and then 90 min at 4°C. After three 5 minute washes with the same buffer, the cells 
were fixed with 2% OsO4 in the same buffer and rinsed again. Cells were then dehy-
drated at 4o C using a graduated series of ethanol concentrations (20%, 50%, 70%, 
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 100%), and subsequent acetone/ethanol mixture (1:1), and finally, 100% acetone. This 
was followed by stepwise infiltration with Epon-Araldyte resin (EM Sciences) over 
the course of 64 hrs. Samples were dispensed into beem capsules, and the resin was 
polymerized at 80°C overnight. Thin sections (60 to 90 nm thick) were collected on 
300-mesh copper grids and viewed in a Philips 201 transmission electron microscope. 
Conventionally rendered negatives of electron microscopic images were scanned by 
using Microtek Scanmaker 5 and Scanwizard Pro PPC 1.02 software. Positive images 
were rendered from digitized negatives with Adobe Photoshop software. 
Results 
The N-terminal domain of pUL31 is functionally important to nuclear egress. 
The HSV-1 UL31 protein is highly conserved among members of the herpesviridae. 
Interestingly, the first 50 amino acids of the N-terminal of UL31 protein share little 
homology at the primary sequence level with other herpesvirus homologs. The clus-
tered charged residues and hydrophilic nature distinguish this region from the remain-
der of HSV-1 pUL31, which is mostly hydrophobic (not shown). To investigate the 
functional relevance of this charged region of pUL31, a truncated UL31 gene UL31(dN) 
lacking the region from codon 2 to 44 was transfected into Hep2 cells and its ability to 
support replication of the UL31 null HSV-1 mutant was determined by plaque assay. 
Plasmids bearing the full length UL31 open reading frame and vector DNA (pCDNA3) 
served as positive and negative controls, respectively. Viral infectivity at 24 hr post 
infection was titrated on UL31 complementing cells. 
As shown in Fig. 4.1A, expression of full length pUL31 increased the yield of in-
fectious virus more than 100 fold above the background levels produced by transfec-
tion of vector DNA. In contrast to this result, the plasmid encoding N-terminally trun-
cated pUL31 produced only a 5-fold enhancement of viral yield over background. This
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Figure 4.1 Functional analysis of the N-terminus of pUL31. (A) Ability of 
pUL31 mutants to support replication of a UL31 null virus. Hep2 cells were 
transfected with a pcDNA3 vector plasmid or plasmids bearing full length 
UL31(FL) or the N-terminally deleted UL31(dN) used in panel A. The cells were 
then infected with the UL31 null virus. Infectivity at 24 hpi was determined by 
freeze/thawing the infected cells, followed by titration on UL31 complementing 
cell lines. Experiments were performed in duplicate. Each histogram represents 
the mean value, and the mean +/- standard deviations are indicated by error bars. 
(B) pUL31 localization and ability to target pUL34 to the nuclear rim. Hep2 cells 
were transfected with plasmids encoding Flag-tagged full length UL31 
[UL31(FL); a to c] or UL31 lacking the first 43 amino acid codons [UL31(dN)] (d 
to f). The cells were then infected with a UL31 null virus. Cells were stained with 
M2 antibody directed against the Flag tag (green) and pUL34 (red), and images 
were captured by confocal microscopy. 
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 result indicated that the N-terminal domain is important for full function of the HSV-1 
UL31 protein. 
To determine the role of the pUL31 N-terminus in targeting the pUL31/pUL34 
complex to the nuclear rim, Hep2 cells were transfected with plasmids encoding either 
full length pUL31, or the N-terminally truncated protein fused to a Flag epitopic tag. 
The cells were subsequently infected with the UL31 deletion virus and were fixed and 
immunostained with the FLAG-specific antibody and polyclonal pUL34-specific IgY. 
As shown in Fig. 4.1B, the full length pUL31-Flag-specific immunostaining colocal-
ized with pUL34-specific immunostaining at the nuclear rim. In contrast to this result, 
the cells expressing pUL31(dN), and subsequently infected with the UL31 deletion vi-
rus contained Flag-specific immunostaining (denoting the location of truncated 
pUL31) mostly in the cytoplasm. Under these conditions, pUL34 specific immu-
nostaining co-localized with pUL31 in the cytoplasm adjacent to the nucleus. The pat-
tern of pUL34-specific immunostaining was reminiscent of the pattern of pUL34 distri-
bution in cells infected with UL31 null viruses (107, 163), and was similar whether or 
not pUL31-Flag was detected in a particular cell. These observations imply that the N-
terminus of UL31 protein is required for strict localization of the pUL31/pUL34 com-
plex to the nuclear rim.  
The pUL31 N-terminal domain harbors multiple phosphorylation sites of the 
viral US3 kinase. The N-terminal sequence of pUL31 is arginine and serine rich, 
which is reminiscent of US3 serine/threonine kinase phosphorylation motifs (155). Be-
cause it was already known that pUL31 was a substrate of pUS3, we hypothesized that 
US3 kinase phosphorylated pUL31 at least some of the putative US3 phosphorylation 
motifs located at its N-terminus. pUS3 phosphorylation sites on pUL31 were therefore 
mapped as follows. The UL31 codons 1-50, 51-165, 155-165, and 255-306 (Fig. 4.2A) 
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 were fused to the gene encoding GST, and the corresponding fusion proteins were pu-
rified from E. coli by GST affinity chromatography. The purified proteins were then 
incubated with recombinant baculovirus-expressed US3 kinase in buffer containing [γ-
32P]-ATP. Reaction components were then separated on an SDS polyacrylamide gel, 
and the gel was stained with Coomassie brilliant blue, dried and exposed to X-ray 
film. As shown in Fig. 4.2B, equal amounts of all four fragments were present in the 
reactions (upper panel), but only the N-terminal 50 amino acids of pUL31 were labeled 
with 32P (lower panel).  
Analysis of the primary sequence of this region indicated that 6 serine residues 
were in a context potentially consistent with pUS3 phosphorylation sites (Fig. 4.2A). 
Of the 6 residues, Serines 11, 24, and 40 completely matched the predicted pUS3 con-
sensus motif (RnXS/T [n>=2]) (155), while the other 3 Serines (S26, 27, and 43) 
could not be excluded since the kinase was found to be more promiscuous than origi-
nally predicted (128). With this in mind, we systematically substituted these serines 
with alanines and tested the corresponding mutants for their capacity to be phosphory-
lated by pUS3 in vitro. The constructs were designated pUL31(SA3) (bearing S11, S24, 
and S40 changed to alanine codons) and pUL31(SA6) which bears all 6 serines (S11, 
24, 25, 26, 40, 43A) changed to alanines. Mixing GST fusion protein bearing these 
mutations with active US3 kinase and [32P-ATP] revealed that wild type pUL31 was 
heavily phosphorylated by US3 kinase, whereas mutating all 6 serines completely 
abolished phosphorylation. In contrast, the SA3 mutations decreased, but did not 
eliminate US3-dependent phosphorylation (Fig. 4.2C). The results revealed that the 
pUL31 N-terminus contains multiple sites that US3 kinase can phosphorylate in vitro, 
and suggests that the protein is phosphorylated by the US3  kinase during infection as 
indicated previously (89). 
111 
 112 
Figure 4.2 Mapping pUL31 phosphorylation sites of pUS3 kinase. (A) Sche-
matic illustration of full length UL31 protein and its sub-fragments used in panel 
B, and the primary sequence showing potential phosphorylation sites (under-
lined). A series of constructs with point mutations used in subsequent experi-
ments are listed. (B) In vitro kinase assay with sub-fragments of pUL31. GST 
fusion proteins purified from E.coli were incubated with purified US3 kinase 
assay with sub-fragments of pUL31. GST fusion proteins purified from E. coli 
were incubated with purified US3 kinase and [γ-P32]ATP. The reaction products 
were electrophoretically separated on a denaturing gel and were stained by 
Coomassie brilliant blue, dried and exposed to X-ray film. (C) Wild type and 
mutant pUL31 reacted with purified US3 kinase in vitro. Reactions were per-
formed as in panel B. Reactants were separated on a denaturing gel, visualized 
by CBB staining, and dried. The presence or absence of phosphorylation was 
determined by autoradiography of the same gel. 
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 Precluding phosphorylation of the pUL31 N-terminus causes a delay in viral 
replication. We next proceeded to determine whether the N-terminus of pUL31 was 
phosphorylated by US3 during viral infection. Recombinant viruses bearing the 6 Ser-
ine to Alanine mutations in UL31 and its corresponding genetically repaired virus 
UL31(SAR) were generated through BAC mutagenesis. Cells were infected with 5.0 
PFU/cell of the wild type virus HSV-1(F), kinase dead virus US3(K220A), UL31 mu-
tant virus UL31(SA6), or the repaired virus UL31(SAR). At 16 hpi, the cells were har-
vested, and electrophoretically separated proteins were subjected to immunoblotting 
with pUL31-specific antiserum.  
The results, shown in Fig. 4.3, indicated that, (i) consistent with previous reports 
(89), phosphatase (PPase) treatment caused an increase in the electrophoretic mobility 
of the pUL31-specific band of HSV-1(F) (lanes 1 and 2). The migration of this band 
was similar to that of non-treated pUL31 from cells infected with US3(K220A) (lane 
3), indicating that pUS3 played an important role in phosphorylation of pUL31 during 
infection directly or indirectly. (ii) The electrophoretic mobility of pUL31 from 
US3(K220A) infected cells was also accelerated by PPase addition (lane 3 and 4), in-
dicating that while pUS3 is important for pUL31 phosphorylation, other kinases also 
play a role. (iii) Substitution of all 6 serines by alanines increased the electrophoretic 
migration of UL31 protein. PPase treatment did not cause a mobility change of this 
mutant (lane 5 and 6) indicating that this was the only phosphorylation site of pUL31, 
at least as detected by one dimensional electrophoresis. In contrast, the mobility of 
pUL31 expressed by the genetically repaired virus UL31(SAR) (lane 7 and 8), was 
greatly increased by PPase treatment, confirming that the pUL31 phosphorylation was 
successfully blocked by the SA6 mutations. (iv) All of the non-mutated pUL31 pro-
teins (lanes 1, 3, 7) produced wider bands than their PPase treated counterparts (lanes 
2, 4, 8), implying the existence of heterogeneously phosphorylated pUL31 species
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Figure 4.3 Immunoblot to determine the phosphorylation state of pUL31 
during infection with wild type and mutant viruses. Hep2 cells were infected 
with wild type HSV-1(F) (lanes 1, 2), US3(K220A) (lanes 3, 4), UL31(SA6) 
(lanes 5, 6), or UL31(SAR) (lane 7, 8) viruses for 16hrs. The lysates were treated 
or untreated with bacteriophage lambda phosphatase as indicated. Cell lysates 
were electrophoretically resolved on denaturing polyacrylamide gels, electrically 
transferred to nitrocellulose, and probed with antibody to pUL31. 
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 during infection. (v) Unexpectedly, the PPase treated UL31 proteins of HSV-1(F) and 
UL31(SAR) viruses (lane 2, 8) migrated slightly slower than the pUL31 of 
US3(K220A) virus. This finding suggested either that not all phosphorylation is pre-
cluded by PPase treatment, or that active US3 kinase induces post-translational modi-
fications other than phosphorylation on pUL31 in infected cells. 
We then conducted one-step viral growth assays to gauge the infectivity of the 
UL31(SA6) virus. Cells were infected with 5 PFU/cell of UL31(SA6), the restored vi-
rus UL31(SAR), wild type HSV-1(F), or US3(K220A) at an MOI of 5 and viral yields 
at the indicated time points were titered on Vero cells. As shown in Fig. 4.4, the 
UL31(SA6) and US3(K220A) viruses displayed a similar pattern of viral growth over 
time. Of note was a nearly 10-fold decrease in titer at 12 hpi compared to that of the 
wild type virus; on the other hand, both recombinant viruses produced titers similar to 
HSV-1(F) at 24 hpi. Impaired viral growth was eliminated by repairing the SA6 muta-
tion inasmuch as the virus UL31(SAR) replicated as efficiently as HSV-1(F). We con-
clude from these data that precluding phosphorylation of pUL31 mimics the growth 
defect of the US3 kinase dead virus. 
Precluding phosphorylation of the pUL31 N-terminus mimics the effects of 
US3 kinase deficiency in pUL31/pUL34 complex localization and perinuclear 
virion accumulation. Although the absence of US3 kinase activity causes a defect in 
capsid nuclear egress, including mislocalization of pUL34 at the nuclear rim and ac-
cumulation of primary enveloped virions in the perinuclear space, the responsible 
kinase substrate has not been identified. Because the growth kinetics of UL31(SA6) 
virus and US3(K220A) were very similar, we compared the localization of pUL34 and 
virions in cells infected with the UL31(SA6) and US3 kinase dead viruses. 
Hep2 cells were infected with either wild type HSV-1(F), US3(K220A),
116 
  
 
 
Figure 4.4 One-step growth curves of wild type and mutant viruses. Hep-2 
cells were infected with either wild type HSV-1(F), US3(K220A), UL31(SA6), or 
UL31(SAR) viruses at an MOI of 5. After adsorption for one hour, residual in-
fectivity was inactivated by a low-pH wash. At the indicated time points, pooled 
intracellular and extracellular viral infectivity was titrated on Vero cells. Ex-
periments were done in duplicate. Mean values are plotted and deviations are 
represented by error bars. 
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 UL31(SA6), or the UL31(SAR) virus for 16 hours, at which time the cells were immu-
nostained with antibodies against pUL31 and pUL34 and visualized by confocal mi-
croscopy (Fig. 4.5). Consistent with previous reports, the pUL31 and UL34 proteins co-
localized smoothly along the nuclear envelope in cells infected with HSV-1(F).  Deac-
tivation of the US3 kinase as in cells infected with the US3(K220A) virus induced dis-
crete foci of pUL31 and pUL34 at the nuclear rim. In cells infected with the UL31(SA6) 
virus, the focal distribution of pUL31/pUL34 appeared very similar to that of cells in-
fected with US3(K220A). The aberrant distribution of pUL31/pUL34 was restored to 
the wild type distribution in cells infected with the genetically repaired virus 
UL31(SAR).  
To examine the effects of pUL31 phosphorylation on the distribution of virions, 
cells were infected with wild type HSV-1(F), US3(K220A), UL31(SA6), or the 
UL31(SAR)viruses, embedded, and thin sections were stained and examined by elec-
tron microscopy. As shown in Fig. 4.6, UL31(SA6) viral infection produced nuclear 
membrane invaginations containing multiple primary enveloped virions. The distribu-
tion of these virions resembled that of cells infected with US3(K220A) virus implying 
an egress defect, but was dissimilar to the appearance of cells infected with HSV-1(F) 
or the restored virus UL31(SAR) (not shown). 
We conclude that phosphorylation of pUL31 is necessary for proper localization 
of the pUL31/pUL34 complex in the nuclear rim, and for optimal egress of virions 
from the perinuclear space. 
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pUL31/pUL34 distribution is dependent on the acidity of the pUL31 N-
terminus. In preliminary studies, localization of pUL31/pUL34 in cells infected with a 
virus [designated UL31(SA3)] expressing pUL31 with point mutations S11A, S24A 
and S40A was undistinguishable from that in cells infected with wild type virus (not
  
Figure 4.5 Confocal immunofluorescence staining of pUL31 and pUL34 in 
HSV-1 infected Hep2 cells. Cells were infected with either the wild type HSV-
1(F) [designated (F)], US3(K220A), UL31(SA6), or UL31(SAR) viruses. After 16 
hours the cells were fixed in paraformaldehyde and methanol, permeabilized, 
immunostained for pUL31 (green) and pUL34 (red), and visualized by confocal 
microscopy. Optical sections were taken through the middle of cells. 
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Figure 4.6 Electron microscopy of Hep2 cells infected with HSV mutants. 
Cells were infected for 16 hours with the indicated viruses, fixed, embedded, 
sectioned, stained, and examined in a transmission electron microscope. Images 
show primary enveloped virion accumulation in Hep2 cells infected by 
US3(K220A) viruses or UL31(SA6) viruses. (N, nucleus; C, cytoplasm). The 
scale in μM is indicated.
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 shown). This observation suggested that phosphorylation at sites S25, S26 and/or S43 
were sufficient to enable pUL31 to function properly. With this in mind, two pseudo-
phosphorylated pUL31 expressing viruses were generated, one termed UL31(SAE) en-
coded residues 11, 24 and 40 as alanines while residues 25, 26 and 43 were changed to 
glutamic acid, and UL31(SE6), which had all six residues changed to glutamic acid 
(diagrammed in Fig. 4.2A).  
Immunoflourescence analysis of the pUL31 and pUL34 distribution in cells in-
fected with these viruses revealed phenotypic differences (Fig 4.7). Specifically, 
UL31(SAE) still produced punctate pUL31/pUL34-specific staining like the UL31(SA6) 
or US3(K220A) viruses, whereas these proteins were distributed smoothly throughout 
the nuclear rim in cells infected with UL31(SE6). Taken together with the distribution 
patterns of pUL31/pUL34 in cells infected with of UL31(SA3) and UL31(SA6) viruses, 
the data indicated that acidity of the pUL31 N-terminus was a critical factor mediating 
pUL31/pUL34 localization.  
In order to confirm the rescuing effect of the acidity of pUL31 in pUL31/pUL34 
complex localization, and to see if effecters of US3 other than UL31 play a role, a 
novel virus was generated in which the mutation abolishing US3 kinase activity was 
introduced into the UL31(SE6) virus, resulting in a double mutant virus 
UL31(SE6)/US3(K220A). Analysis of the distribution of the pUL31/pUL34 complex in 
cells infected with this mutant indicated that the complex localized in a smooth distri-
bution at the nuclear rim in contrast to what would be expected in cells infected with 
US3(K220A). Thus the rescuing phenotype of completely pseudo-phosphorylated 
pUL31 was dominant over the inactive US3 kinase phenotype. These observations sug-
gested that pUL31 is the major substrate of US3 kinase responsible for regulating the 
localization of pUL31/pUL34 at the nuclear rim. 
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Figure 4.7 pUL31 and pUL34 localization in Hep2 Cells infected with 
pseudo-phosphorylated UL31 viruses.  Hep2 cells were infected with the indi-
cated viruses and were fixed at 16 hours after infection in paraformaldehyd and 
methanol. The cells were then immunostainned for pUL31 (green) and pUL34 
(red) and visualized by confocal microscopy. Optical sections were taken 
through the middle of cells. 
123 
 Pseudo-phosphorylated pUL31 inhibits primary envelopment of nucleocap-
sids. Based on the immunofluorescence data above, we presumed that unlike the US3 
kinase-dead virus, (i) the UL31(SE6) virus and UL31(SE6)/US3(K220A) viruses would 
not induce herniations of nuclear membrane containing perinuclear virions, and (ii) 
would replicate as efficiently as wild type HSV-1. To test the first prediction, cells 
were infected with these viruses and examined by electron microscopy 16 hours later.  
Consistent with the first hypothesis, no excessive perinuclear virion accumulation was 
observed in cells infected with either virus over that seen in cells infected with wild 
type HSV-1(F). Inconsistent with the second hypothesis, however, very few viral par-
ticles were detected in the cytoplasm or on the cell surface of cells infected with the 
UL31(SE6) or UL31(SE6)/US3(K220A) viruses. This was the case despite ample num-
bers of capsids within nuclei of these cells. Counting a representative 9 cell sections 
indicated that whereas the ratio of cytoplasmic to intranuclear capsids was approxi-
mateley 1.55 in cells infected with HSV-1(F), this ratio was only 0.11 in cells infected 
with the mutant virus UL31(SE6) virus and 0.02 for the UL31(SE6)/US3(K220A) dou-
ble mutant (Table 4.3). These data suggest that the mutant virions were enveloped at 
the inner nuclear membrane less efficiently than their wild type counterparts.  
To further investigate the phenotype of the UL31(SE6) and 
UL31(SE6)/US3(K220A) viruses, cells were infected with these viruses at 5.0 PFU/cell 
and the amount of infectious virus was determined at various times after infection. As 
shown in Fig. 4.8, the UL31(SE6) and UL31(SE6)/US3(K220A) viruses produced less 
infectious virus throughout the infection compared to HSV-1(F). The most marked 
discrepancy was observed at 12 hpi, when the amount of infectious UL31(SE6) virus 
was reduced approximately 10 fold compared to that of HSV-1(F), whereas the 
UL31(SE6)/US(K220A) virus titer was reduced more than 20 fold. As shown previ-
ously, the US3(K220A) virus also displayed a 10 fold lower titer at 12 hpi compared to
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Table 4.3 Subcellular distribution of viral particles in Hep2 cells infected for 16 
hrs (examined by EM). 
Total intracellular viral particle numbers 
Virus 
Nuclear (N) Cytoplasmic (C) 
Perinuclear 
(PN) 
Cells 
counted 
Average 
Ratio 
(C/N) 
HSV-1 (F) 73 113 10 9 1.55 
UL31(SE6) 186 21 0 9 0.11 
UL31(SE6)/ 
US3(K220A) 
129 3 2 9 0.02 
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Figure 4.8 One-step growth curves of pseudo-phosphorylated UL31 viruses. 
Hep-2 cells were infected with either wild type HSV-1(F), US3(K220A), 
UL31(SE6), or UL31(SE6)/US3(K220A) at an MOI of 5 PFU/cell. Residual vi-
ruses were inactivated by a low-pH wash at 1 hpi. At the indicated time points, 
virus in the whole culture was collected and titrated on Vero cells. Experiments 
were done in duplicate. Mean values are plotted and simple standard deviations 
are represented by error bars. 
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 HSV-1(F) but eventually produced infectious virus titers approaching those of the wild 
type virus. In contrast to this result, the two UL31 mutants reached their peak titers at 
18 hpi, and never reached infectious titers approaching those of wild type HSV-1(F). 
These data indicate that the nuclear egress defects of the UL31 mutants are more per-
sistent than that of the US3(K220A) virus, suggesting a defect in primary envelopment 
that does not diminish as infection proceeds. We also noted that the double mutant 
UL31(SE6)/US3(K220A) replicated slightly less efficiently than either of the viruses 
with single mutations, indicating that the pseudo-phosphorylated pUL31 is insufficient 
to complement fully the contribution of US3 kinase activity to viral infectivity. 
Discussion 
Normally, nucleocapsid budding through the inner nuclear membrane and fusion 
of the nascent virion envelope with the outer nuclear membrane is highly efficient. 
This conclusion comes from the observation that during wild type virus infection, 
there is rarely extensive virion accumulation in the perinuclear space. In cells infected 
with US3 kinase-dead viruses however, the accumulation of perinuclear virions in her-
niations of the perinuclear space is commonplace. This aberrant virion accumulation 
likely reflects an imbalance between the rate of delivery into localized regions of the 
perinuclear space and the rate of exit from these regions. Taken from this perspective, 
the US3 kinase might serve to decrease the numbers of virions in particular perinuclear 
regions because its activity disperses the nuclear envelopment complex widely 
throughout the nuclear membrane. Thus, the rate of exit from the nucleoplasm is simi-
lar to wild type virus, but the number of envelopment sites is increased, and perinu-
clear virions do not accumulate in particular regions. On the other side of the inner 
nuclear membrane, US3 may promote fusion of the perinuclear virion envelope with 
the outer nuclear membrane.  
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 Perhaps the most important finding of the current work is that most of the US3 
nuclear egress phenotype, including mislocalization of the pUL31/pUL34 complex and 
virion accumulation in herniations of the perinuclear space, can be mimicked by pre-
cluding phosphorylation of pUL31 at its N-terminus. Thus, US3 mediates much of its 
effects in nuclear egress through phosphorylation of pUL31. Aggregation of 
pUL31/pUL34 may restrict sites of budding causing nucleocapsids to continue budding 
into herniations already containing multiple perinuclear virions, thereby overwhelming 
the fusion machinery. There is otherwise no evidence that the rate of budding into the 
perinuclear space is impaired by the absence of phosphorylation of pUL31.   
Our data also indicate that the pseudo-phosphorylated pUL31(SE6) is defective in 
primary envelopment of nucleocapsids at the INM, and is insufficient to complement 
the full function of US3 kinase. Thus, some functions of US3 kinase activity important 
to viral replication are mediated by substrates other than pUL31. We speculate that 
these other substrates may include an impaired or mis-triggered fusion apparatus that 
mediates fusion between the virion envelope and ONM (possibly mediated through gB 
and gH). It is unclear whether the pUL31(SE6) mutation interferes with the fusion 
event because the paucity of perinuclear virions in cells infected with this mutation 
precludes assessment of this possibility.  
  Together, the data suggest that the function of pUL31 is tightly and dynamically 
controlled by phosphorylation. Based on all the data presented herein, we hypothesize 
that there is a mixed population of both unphosphorylated and phosphorylated pUL31 
(Fig. 4.9). At primary envelopment sites in the inner nuclear membrane, the unphos-
phorylated form is involved in initiation of the budding reaction, possibly by direct or 
indirect interaction with the nucleocapsid or other egress components, whereas the 
phosphorylated form coexists and is required to prevent pUL31/pUL34 aggregation. 
Once in the perinuclear space, pre-existing or newly phosphorylated pUL31 is needed
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Figure 4.9 Proposed model of dynamic phosphorylation of pUL31 during 
HSV nuclear egress. In HSV infected cells, phosphorylated pUL31 are scattered 
through the inner nuclear membrane (INM) via interaction with pUL34. DNA-
filled capsids (1) contact the INM at the sites where unphosphorylated pUL31 are 
concentrated to inititate the primary envelopment reaction (2). Capsids translo-
cate into the perinuclear space (PNS) with an envelope containing fusion pro-
teins (3). In the PNS, phosphorylated forms of pUL31 induce conformational 
changes in the fusion proteins (4). These alterations trigger the fusion of the en-
velope with the outer nuclear membrane (ONM) and subsequent release of cap-
sids into the cytoplasm (5). 
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 to promote the fusion of the perinuclear virion with the ONM, probably by altering 
protein-protein interactions to activate the fusion proteins gH and gB. 
Finally, we note that in our previous study of cellular lamin A/C, we reasoned 
that one possibility to explain the punctate distribution of pUL31/pUL34 in cells in-
fected with US3 kinase-dead viruses was that this aberrant distribution reflected mobil-
ity constraints caused by a hypophosphorylated, and therefore less permeable, nuclear 
lamina. The current observation that the UL31/UL34 proteins are of punctate distribu-
tion in cells infected with the UL31(SA6) mutant argue against this possibility because 
these cells contain active pUS3, which would be expected to phosphorylate lamin A/C. 
Thus phosphorylation of lamin A/C is separable from functions required for the proper 
localization of pUL31/pUL34. 
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CHAPTER V 
SUMMARY AND FUTURE STUDIES 
Summary 
The research goal of my study is to understand the machinery mediating the nu-
clear egress of HSV-1 capsids. The work initiated with the observation that in cells 
infected with a mutant HSV defective in US3 kinase, enveloped virions accumulate in 
invaginations of the inner nuclear membrane (INM), and viral production is delayed 
compared to wild type HSV-1(F) virus. The kinase therefore is postulated to regulate 
the capsid egress from the nucleus. This process involves primary envelopment at the 
INM and de-envelopment at the outer nuclear membrane (ONM) and requires the 
UL31 and UL34 proteins. Several substrates of pUS3 have been identified and investi-
gated for their role in this process, but had yet to be implicated.  
In order to determine the US3 substrate(s) responsible, an in vitro assay system 
using baculovirus-expressed pUS3 was established. As shown in Chapter II, nuclear 
lamin A/C was identified as a potential substrate and could be dissolved partially in 
vitro by US3 kinase activity. This was further confirmed by an in vivo assay showing 
that lamin A/C was hyper-phosphorylated during HSV infection and a full spectrum of 
phosphorylation required pUS3 activity. The nuclear lamina was found to be dramati-
cally perforated when US3 kinase was deactivated; and the essential nuclear egress 
complex pUL31/pUL34 aggregated near those lamina perforations. Given that phos-
phorylation is a common strategy to rearrange lamina structure, I hypothesized that the 
lack of pUS3 activity caused a decrease in the phosphorylation of lamin A/C, which in 
turn made the lamina less flexible and hence restricted the pUL31/pUL34 distribution. 
However, an alternative possibility was that pUL31/pUL34 aggregation might me-
chanically perforate the lamina.  
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 The nuclear lamina has long been considered a potential barrier for viral capsids 
to access primary envelopment sites at the inner nuclear membrane; together with the 
above hypothesis, I proceeded to investigate the roles of certain types of lamins during 
HSV-1 infection, using lamin knockout MEFs. In chapter III, pUL34 positioning and 
general permissivity of wild type and US3 kinase dead viral infection was examined in 
Lmna-/- or Lmnb1-/- MEFs.  I found the two lamin types contributed differently to viral 
infection. Lamin A/C was dispensable for the infections. In particular, the replication 
of US3 kinase dead virus was augmented and produced no perinuclear virion accumu-
lation. The localization of pUL34 was slightly altered upon the loss of lamin A/C in 
both viral infections, but it still aggregated in discrete foci in the absence of US3 
kinase activity. In contrast, lamin B1 was required for efficient replication of both vi-
ruses. US3 mutant virus still induced perinuclear virion herniations, although pUL34 
aggregated in a less extensive fashion. These findings led to the conclusions that (i) 
lamin A/C and lamin B1 have different roles during HSV-1 infection; (ii) 
pUL31/pUL34 aggregates independently of lamin proteins, although lamins do play a 
direct or indirect role modifying the localization of the complex. 
The substrate mediating pUS3 activity was finally discovered, as described in 
chapter IV. pUL31 was recognized as the major downstream effecter of pUS3 regula-
tory pathway by using a phosphorylation-deficient UL31 mutant that reproduced the 
defect seen in cells infected with the US3 mutant virus, even in the presence of the ac-
tive US3 kinase. The mimicked defects included pUL31/pUL34 aggregation, perinu-
clear virion herniations, and slower viral replication kinetics. I went on to further con-
firm and characterize the functional significance of the pUS3/pUL31 catalytic relation-
ship and found some interesting results. When pUL31 was constantly phosphorylated 
in an artificial manner, pUL31/pUL34 was properly positioned on the nuclear rim but 
the primary envelopment of capsids was impaired. Introducing a mutation ablating 
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 US3 kinase activity did not alter the distribution of the pUL31/pUL34 complex or in-
duce nuclear membrane herniations, but the viral replication was more decreased than 
with either mutation alone. These data imply that phosphorylation of pUL31 may be a 
dynamic event during infection and also that pUS3 has to phosphorylate substrate(s) 
other than pUL31 to exert its full contribution to HSV-1 replication. Hence, I propose 
that there is a mixed population of pUL31. The unphosphorylated form is present to 
initiate the primary envelopment process by interacting with capsids or other egress 
components, while the phosphorylated form is required to prevent pUL31/pUL34 com-
plex from aggregating. At the subsequent de-envelopment stage, phosphorylation of 
pUL31 and other substrates are needed to promote the fusion of the nascent viral enve-
lope with the ONM. 
Future studies 
(i) The proposed model of pUL31 phosphorylation does not address whether there 
are two static or interchanging populations of pUL31 and what is their relative ratio. 
Hence it will be interesting to determine when cells are co-infected by the phospho-
deficient UL31(SA6) and pseudo-phosphorylated UL31(SE6) viruses, how these two 
static pUL31 populations will interact. An approach allowing precise switch-off and -
on of the US3 kinase activity will be very useful to characterize the process in more 
spatial and temporal details. To achieve this goal, solving pUS3 structure and generat-
ing a specific inhibitor to the kinase would be useful.  
(ii) The core question remaining unanswered is the specific mechanism by which 
the pUL31/pUL34 complex initiates primary envelopment of capsids. Co-expressing 
the pUL31/pUL34 homologs of pseudorabies virus is sufficient to induce vesicles de-
rived from the INM in the absence of other viral proteins (91). Therefore, it is neces-
sary to test if pUL34 alone is capable of such a function inasmuch as pUL34 can be 
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 properly targeted to the INM in rabbit skin cells in the absence of pUL31, and pUL31 is 
less essential for viral replication in this particular cell line (107).  
Since the research strategies are hampered by difficulties involved in working 
with nuclei, it will be very useful if we could reconstruct primary envelopment ma-
chinery on the plasma membrane. pUL34 is a type II membrane protein and may be 
delivered to the cell surface via genetic engineering or by interaction with synthesized 
liposomes. pUL31 is easier to manipulate because its NLS is in the poorly conserved 
N-terminal domain that appears to be dispensable for interaction with pUL34 (unpub-
lished data). If the system works, and budding vesicles are induced from plasma mem-
brane, it means the process does not need nuclear components, and the vesicles can be 
harvested for composition analysis to identify additional cellular factors. 
Alternatively, leaving pUL31/pUL34 on the nuclear rim, we may take advantage 
of the aggregates induced by the US3 mutation, with the assumption that the essential 
egress components are enriched in these pUL31/pUL34 containing microdomains. In 
this case, cross-linking and in vivo labeling strategies may allow us to isolate func-
tional candidates. 
(iii) It is equally important to determine the structure of pUL31 and pUL34. Pri-
mary sequence analysis only inefficiently predicts any obvious structural or functional 
domains in the two proteins. In particular, it is indicated in Chapter IV that the phos-
phorylation at pUL31 N-terminus may induce significant conformational changes in 
the protein that is required for efficient primary envelopment and de-envelopment. 
Therefore, structural analysis will greatly help elucidate the nature of the protein func-
tions. 
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